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ABSTRACT 
 For better translation from basic science to everyday clinical practice, biomedical 
research must attempt to understand cellular behavior that occurs in vivo.  This is 
assuredly a daunting task as cells receive many cues from the surrounding 
microenvironment.  Cues such as changes in the extracellular matrix, gradients of 
soluble molecules, or reduced oxygen tensions will cause cells to alter their behavior.  
To more thoroughly understand how these cues alter cellular processes, advanced 
platforms capable of mimicking these microenvironments are necessary.  Microfluidic 
platforms have the potential to enable systematic studies of cell behavior in these 
complex microenvironments.  Microfluidic platforms provide control over the chemical 
microenvironment.  This inherent control enables generation of linear chemical 
concentration gradients, control over diffusion of soluble molecules, and regulation of 
gaseous conditions.  This work aims at developing and applying microfluidic platforms 
to study (1) neutrophil chemotaxis, (2) intercellular communication, and (3) cell behavior 
under controlled oxygen conditions. 
In chapter 1, conventional methods and emerging techniques using microfluidic 
platforms to study cell behavior in complex microenvironments are discussed.  In 
chapter 2, the study of neutrophil chemotaxis in competing chemical concentration 
gradients using a microfluidic platform is discussed.  Neutrophils were observed to 
oscillate between the maxima of the two intermediary chemoattractants LTB4 and IL-8.  
Chapter 3 discusses the design and characterization of a microfluidic platform with 
barriers that act as bifurcations in the path of neutrophil migration.  Neutrophils were 
found to efficiently migrate around 40-µm and 100-µm wide barriers.  However, when 
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the barrier width was increased to 200 µm neutrophils took an inefficient, tortuous path.  
In chapter 4, the design, operation, and application of a microfluidic platform that 
enables the study of intercellular communication is discussed.  A model system was 
used to experimentally measure and computationally simulate intercellular 
communication within the device.  The agreement of these two techniques enabled the 
complete description of spatiotemporal distribution of signaling molecules in the 
microfluidic platform.  In chapter 5, methods to study the tumor microenvironment 
under controlled oxygen conditions were discussed.  This chapter details characteristics 
of the tumor microenvironment.  Further, the advantages and limitations of conventional 
methods and recently developed microfluidic platforms were discussed in detail.  
Chapter 6 discusses the design, fabrication, operation, and validation of an open-welled 
microfluidic platform that enables control over oxygen concentration during cell studies.  
The oxygen concentration within the microfluidic platform was experimentally measured 
and computationally simulated as different parameters of the platform were varied.  
Overall, this dissertation discusses the design and use of microfluidic platforms to study 
cell behavior in complex microenvironments.  
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CHAPTER 1 
Introduction to cell studies in microfluidic platforms 
As our understanding of cell biology increases, advanced tools are required to 
better study cell behavior in complex microenvironments.  These microenvironments 
influence cell behavior and include interactions with other cells, interactions with the 
extracellular matrix, gradients, and low oxygen tensions. Microfluidic platforms provide 
control over the cellular microenvironment in a highly precise manner, thereby enabling 
studies not possible with conventional, macroscale tools. Thus, by employing 
microfluidic platforms research aimed at understanding the individual and coordinated 
role of these complex microenvironments is possible. 
1.1. Chemotaxis in microfluidic platforms 
Chemotaxis, the process of directed migration up a chemical concentration 
gradient, is an important biological function.  Chemotaxis occurs during wound healing 
[1,2], metastasis [3-5], tissue and organ development [6,7], and clearance of bacterial 
infections during the immune response [8-11].  Further, aberrant neutrophil chemotaxis 
has been associated with rheumatoid arthritis [12-14], asthma [15,16], and chronic 
inflammation [17,18].  During an infection, neutrophils are recruited via soluble and 
substrate-bound gradients of a variety of different chemoattractants, and contact 
guidance with extracellular matrix (ECM) fibers [19].  These gradients and ECM fibers 
are often misaligned, creating a complex multi-cue environment that the cells must 
efficiently navigate.  However, studying neutrophil chemotaxis in these complex 
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microenvironments is challenging due to difficulties controlling mass transfer in 
conventional assays. 
Conventional methods to perform chemotaxis studies consist of the Zigmond 
chamber [20], under-agarose assay [21-23], and micropipette assay [24-27].  These 
methods have enabled the investigation of previously unidentified biomolecules that 
elicit chemotaxis as well as the mechanisms by which this migration is directed [28].  
However, these methods are limited in their ability to create complex microenvironments 
[29].  Specifically, the Zigmond chamber is limited by the one hour lifespan of its 
gradients.  Further, the Zigmond chamber is unable to produce multiple gradients at one 
time.  Beyond the Zigmond chamber, the under-agarose assay provides little control 
over the spatiotemporal evolution of gradients and often gradients are generated with 
poor reproducibility.  The micropipette assay suffers from limitations that are similar to 
the under-agarose assay.  Specifically, the micropipette assay does not generate 
reproducible or controllable gradients.  While these conventional methods have 
uncovered important aspects of chemotaxis, further elucidation of this phenomenon 
may be dependent upon the ability to generate multiple stable gradients reproducibly. 
With the advent of microfluidic technologies, quantitative studies of cell migration 
have become possible.  Microfluidic platforms can generate reproducible, rapidly-
forming, stable, linear and complex gradients.  This precise control over chemical 
gradients makes microfluidic platforms well suited for chemotaxis assays [30].  For 
example, neutrophil chemotaxis in a microfluidic platform was demonstrated by 
generating various IL-8 concentration gradients [31].  This device was also used to 
study the effect of gradient steepness versus mean concentration as well as behavior in 
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opposing chemoattractant gradients [21,32-35].  The effect of gradient steepness 
versus mean concentration was studied further by generating an exponential gradient 
[36].  Simple ‘Y type’ designs were applied to study T cell chemotaxis and signaling 
pathways in HL-60 cells [37,38].  More complex platforms have been developed to 
study neutrophil response to dynamic gradients [39-41].  In addition, bifurcating or 
narrow channels that constrain cell migration were fabricated to analyze how 
neutrophils sense gradients [42,43].  An arrayed device has been used to diagnose 
patients and study intracellular processes [44,45].  Altogether, microfluidic platforms 
have helped provide insight into mechanisms and behaviors during chemotaxis [46].  
Still, more systematic studies of cell behavior under complex microenvironments are 
needed to obtain a deeper understanding of chemotaxis. 
1.2. Intercellular signaling in microfluidic platforms 
Paracrine signaling is a form of intercellular communication that occurs when a 
cell produces a molecule to induce changes in nearby cells.  This form of 
communication can elicit an immune response [47-49], enable stem cell proliferation 
and differentiation [50-52], stimulate tumorigenesis [53,54], or promote metastasis 
[5,55-57].  In vivo, cells situated in 3D environments constantly communicate with 
surrounding cell types via diffusion of molecules.  During this communication, gradients 
of the secreted factors evolve over time, inducing a response from nearby cells [58].  
However, the conventional methods used to study intercellular communication do not 
have the required spatiotemporal control over signaling molecule gradients.  Thus, to 
investigate the complex interactions that occur between different cell populations, new 
methods that mimic in vivo must be employed.  
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The most commonly used method to study cell-cell communication is the 
transwell assay [59].  In this technique, cell type A is grown in a well-plate.  An insert 
with a porous membrane bottom is seeded with cell type B.  The insert is placed in the 
well-plate, enabling signaling molecules to diffuse across the porous membrane.  
Depending upon the cell-cell communication, cell type B can migrate through the porous 
membrane.  The transwell assay is easy to perform and provides a quantitative 
measure of the level of transmembrane migration.  However, limitations with this 
method prevent detailed studies of intercellular signaling.  Specifically, the signaling 
molecule gradient that forms across the membrane cannot be controlled.  In addition, 
the concentration of signaling molecules is diluted due to large volumes of media [60].  
Thus, while the transwell assay has enabled initial studies of intercellular 
communication, platforms that provide increased control over the formation of gradients 
and physiologically relevant signaling molecule concentrations are necessary for 
advanced studies. 
Microfluidic platforms allow for precise control over cell seeding, cell culture, and 
the chemical microenvironment [61-64].  Hence, microfluidic platform enable effective 
delivery of nutrients and soluble molecules as well as the placement of multiple cell 
types.  In addition to these attributes, microfluidic platforms have relevant biological 
length scales (~100 μm).  The appropriate length scale is beneficial in terms of diffusion 
times as well as reduced dilution of signaling molecules [58].  These characteristics 
have enabled studies of intercellular communication.  Specifically, methods to pattern 
cells inside microfluidic platforms to study cell signaling have been developed using 
laminar flow [63,65,66].  Others have developed microfluidic platforms to study cell 
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migration under co-culture [61,67-69].  Microfluidic platforms to specifically study 
intercellular communication between two cell types have also been described [62,70-
73].  However, these platforms are largely two dimensional (2D), lack control over 
diffusion of soluble molecules and gradient formation, or are restricted in the spacing of 
channels.  More specifically, the limitation of culturing cells in 2D affects the 
physiological relevance and has been shown to differ significantly from 3D cultures 
[54,74-76].  Thus, further development of microfluidic platforms that enable 
communication of multiple cell populations which are patterned in three-dimensional 
hydrogels is necessary going forward.  
1.3. Hypoxic cell studies in microfluidic platforms 
Recent estimates suggest that 50% of all people living in the United States will 
be diagnosed with cancer at some point during their lifetime [77].  In most solid tumors 
such as breast cancer, oxygen availability is limited due to poorly arranged and 
malfunctioning vasculature [78,79].  These hypoxic or low oxygenated regions have 
been demonstrated to promote tumor progression [80,81], increase therapeutic 
resistance [82-84], and increase metastasis through the epithelial-mesenchymal 
transition [85-87].  On a molecular level, hypoxia alters cell metabolism [88,89], cell 
growth [90,91], and the stage of cellular differentiation [92,93].  While the affects of 
hypoxia on the tumor microenvironment have been resolved, the molecular 
underpinnings governing this cellular behavior are still largely unclear [94].  Thus, 
further methods to study tumor progression and cell behavior under controlled oxygen 
conditions are needed. 
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To study tumor progression and cell behavior under hypoxia, the tools and 
methods to create these low oxygen conditions must be amenable to the conventional 
cell biology assays being preformed [95].  Specifically, newly developed tools must have 
precise control over the oxygen concentration.  Hypoxia-inducible factor (HIF), an 
important transcription factor regulating more than 100 genes, has been shown to 
stabilize and accumulate to different levels at varying oxygen concentrations [96,97].  
Beyond controlling oxygen conditions, cells and reagents must be easily added, 
handled, and manipulated.  Easy addition and manipulation of reagents is necessary to 
perform most cell assays. Specifically, addition of oxidants and reductants is needed to 
study organellar redox under low oxygen conditions [98,99].  Another requirement for 
future methods to study cell behavior under controlled oxygen conditions is real-time 
imaging [100].  Real-time imaging enables studies of cell migration, reactive oxygen 
species generation, and therapeutic sensitivity that are otherwise challenging to perform 
under controlled oxygen conditions.  Overall, requirements for the tools used to create 
low oxygen conditions may vary depending on the specific study performed, but control 
over oxygen concentration, easy manipulation of reagents, and real-time imaging are 
necessary for a thorough understanding of cell behavior under hypoxia. 
Microfluidic platforms provide the ability to both control oxygen conditions and 
perform cell studies [95,100].  The ability to regulate oxygen concentration is largely due 
to the characteristic control over mass transport that microfluidic platforms possess 
[101].  Further, microfluidic platforms reduce the time required for diffusion and 
equilibration of oxygen compared to conventional methods [102].  This feature is 
particularly helpful when time-dependent studies of cell behavior are being performed.  
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In addition, microfluidic platforms are compatible with high resolution microscopy, 
enabling real-time imaging of cell behavior under low oxygen conditions. Thus, 
microfluidic platforms have the potential to enable detailed cell studies while controlling 
oxygen concentration. 
A number of microfluidic platforms have been developed to control oxygen 
conditions during cell studies.  These platforms employ a number of different techniques 
to control the oxygen concentration.  For example, methods using chemicals and 
chemical reactions to control oxygen concentrations have been developed [103,104]. 
Another reaction, electrolysis, was also used to control the amount of oxygen in the 
device [105].  In another case, a platform using Braille pins as valves was employed to 
create oxygen gradients [106].  Other platforms have been fabricated out of oxygen 
impermeable materials [107-110].  By utilizing these alternative materials, the diffusion 
of oxygen from atmospheric air into the device was drastically reduced.  Another 
technique controls the oxygen concentration by positioning the cell chamber adjacent to 
the gas supply channels [111-117].  While these platforms have demonstrated the 
ability to control oxygen concentration during cell studies, further development and 
characterization of platforms is needed for microfluidics to truly reach their potential as 
tools to study cancer cell behavior under hypoxia. 
1.4. Overall objectives 
The overall objective of my research is to develop microfluidic platforms for cell 
behavior studies in complex microenvironments.  Conventional methods to perform 
these studies are largely limited by their inability to control mass transfer.  By creating 
platforms on the microscale, fluid flow is in the laminar regime and, thus, mixing occurs 
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only by diffusion.  This method of mixing enables generation of linear chemical 
concentration gradients, distribution of signaling molecules, and control over oxygen 
conditions.  These platforms enable studies of neutrophil chemotaxis, intercellular 
signaling, and cancer cell behavior in complex microenvironments.  The information 
uncovered while using these platforms will further help in the understanding and 
treatment of diseases and disorders such as cancer, asthma, inflammation, wound 
healing, and rheumatoid arthritis. 
My research can be divided into three distinct categories.  In these categories, 
we studied (1) neutrophil chemotaxis in complex chemoattractant environments and in 
bifurcating channels; (2) intercellular communication in a 3D microenvironment; and (3) 
cell studies under controlled oxygen concentrations.  To study each of these biological 
behaviors, a specific microfluidic platform was designed and developed to overcome 
current limitations with conventional approaches.  A proof-of-principle study was then 
performed to demonstrate the utility of the developed microfluidic platform. 
This dissertation presents microfluidic platforms for studying cell behavior in 
complex microenvironments.  Chapter 2 discusses the study of neutrophil chemotaxis 
in competing chemical concentration gradients.  Neutrophils were found to oscillate 
between the maxima of the two intermediary chemoattractants LTB4 and IL-8.  Chapter 
3 discusses the design and characterization of a microfluidic platform with barriers that 
act as bifurcations in the path of neutrophil migration.  Neutrophils were found to 
efficiently migrate around 40-µm and 100-µm wide barriers.  However, when the barrier 
width was increased to 200 µm neutrophils took an inefficient, tortuous path.  Chapter 4 
discusses the design, operation, and application of a microfluidic platform that enables 
 9 
the study of intercellular communication.  A model system was used to experimentally 
measure and computationally simulate intercellular communication within the device.  
The agreement of these two techniques enabled the complete description of 
spatiotemporal distribution of signaling molecules in the microfluidic platform.  In 
chapter 5, methods to study the tumor microenvironment under controlled oxygen 
conditions were discussed.  The advantages and limitations of conventional methods 
and recently developed microfluidic platforms were discussed in detail.  Chapter 6 
discusses the design, fabrication, operation, and validation of an open-welled 
microfluidic platform that enables control over oxygen concentration during cell studies.  
The oxygen concentration within the microfluidic platform was experimentally measured 
and computationally simulated as different parameters of the platform were varied.  
Finally, chapter 7 summarizes the key conclusions from this work and describes the 
future directions of this project.  
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CHAPTER 2 
Chemotaxis in competing chemoattractant gradients 
¥ 
2.1. Introduction 
Neutrophil chemotaxis plays a prominent role in the innate immune response [1-
3].  A number of chemical signals are produced at sites of infection or inflammation and 
then diffuse into the surrounding tissue [4,5].  Neutrophils sense these chemoattractants 
and move in the direction where their concentration is greatest, thereby locating the 
source of the chemoattractants and their associated targets.  Neutrophils respond to 
many different chemoattractants including: (i) formyl-methionylleucylphenylalanine 
(fMLP) secreted by the infecting microbes [6-8]; (ii) chemokines such as interleukin-8 
(IL-8), growth-related gene product α (GROα), leukotriene B4 (LTB4), and stromal cell-
derived factor 1 (SDF-1) secreted by endothelial cells, mast cells, monocytes, and also 
by neutrophils themselves [9-16]; (iii) a glycoprotein fragment, C5a, produced by the 
complement system [17,18]; and (iv) hydrogen peroxide, produced by damaged tissue 
[19,20].  Each one of these chemoattractants is able to elicit directed cell migration.  
However, when homing in on their targets, neutrophils are confronted with a complex 
array of these chemoattractants emanating from multiple sources.  For instance, 
neutrophils encounter intermediate chemoattractants, such as IL-8 and LTB4, on the 
surface of the endothelium and adhere [21-23].  There, the cells are presented with 
additional chemoattractant gradients and must migrate away from these initial 
chemoattractants toward the source of other chemoattractants.  Clearly, neutrophils 
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need to distinguish between these various signals and employ some sort of logic to 
prioritize among them. 
Previous studies have shown that neutrophils selectively migrate toward end-
target chemoattractants such as fMLP and C5a even when opposing gradients of 
endogenous, intermediate, chemoattractants are present [24-26].  These results 
demonstrate that neutrophils discriminate between chemoattractants and will 
preferentially migrate toward those produced proximal to sites of infection.  The logic is 
less clear when neutrophils are confronted with competing gradients of intermediate 
chemoattractants. Foxman and coworkers, for example, found that when confronted 
with opposing gradients of IL-8 and LTB4, neutrophils tended to migrate toward the 
more distant attractant source and away from the more proximal one, independent of 
the chemoattractant species [25].  They hypothesized that such a mechanism enables 
neutrophils to navigate stepwise through sequential fields of intermediate 
chemoattractants while homing in on their end target.  Meanwhile, others have utilized 
microfluidic devices to study neutrophil migration in opposing IL-8 and LTB4 gradients 
[24,27,28].  These efforts have focused particularly on the prioritization between these 
chemicals in the short term, such as whether LTB4 can influence chemotaxis towards IL-
8. 
While the mechanism for the signaling hierarchy between chemoattractants is not 
known, current results suggest that the two classes operate along different signal 
transduction pathways altogether - in particular, chemotaxis to the end-target attractants 
fMLP and C5a involves the p38 mitogen-activated protein kinase (p38 MAPK) pathway, 
whereas chemotaxis towards IL-8, LTB4, and MIP-2 likely involves the 
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phosphatidylinositol-3-OH (PI3K)/phosphatase and tensin homolog (PTEN) pathway 
[8,24,29].  The crosstalk between these pathways is thought to involve PTEN, a known 
PI3K antagonist, via p38 MAPK-mediated recruitment to the cell circumference [26,30].  
Consequently, in the presence of any end-target chemoattractant, chemotaxis toward 
the intermediary attractants is suppressed [24,25,28,31]. 
In this chapter, we investigated neutrophil chemotaxis in opposing linear 
gradients of chemoattractants using microfluidic devices.  Extending the results of 
Foxman and coworkers, we demonstrate that neutrophils will migrate back and forth in 
oscillatory manner when confronted with opposing gradients of IL-8 and LTB4.  Based 
on these results we developed a mathematical model of neutrophil chemotaxis in 
collaboration with Yuki Kimura and Professor Christopher Rao’s research group.  The 
modeling results and associated analysis demonstrates that basic sensory adaptation 
alone cannot explain the oscillatory migration patterns observed in our experiments.  
Rather, our results support a model where cells reversibly lock on and off different 
chemoattractant signals.  Using this model, we show how this mechanism allows 
neutrophils to locate the sites of infection in the face of complex chemoattractant cues. 
2.2. Materials and methods 
Microfluidic device fabrication.  The microfluidic device was comprised of a 
molded poly(dimethylsiloxane) (PDMS, General Electric RTV 650 Part A/B) slab bonded 
to a glass substrate.  High resolution printing (5080 dpi) was used to print the mask with 
the design pattern on a transparency film.  The mask was used to fabricate 50 µm high 
SU-8 2050 photoresist (Microchem) features on a silicon wafer via photolithography. 
PDMS molds with embossed channels were fabricated using soft lithography by curing 
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the pre-polymer on the silicon master for 2 hours at 70ºC.  The PDMS replica was then 
peeled off the silicon master.  Inlets and outlets for the fluids and cells were created in 
PDMS using a steel punch.  The surface of the PDMS replica and a clean glass 
coverslip (Fisher Scientific) were treated with air plasma for 90 seconds (Model PDC-
001, Harrick Scientific) and irreversibly bonded to complete the device assembly 
(Figure 2.1). The device inlets were then connected to 1 mL syringes (BD Biosciences) 
with 23 G ¾ size needles (BD Biosciences) via PTFE tubing (Cole-Parmer).  All 
syringes were calibrated and pushed by a constant pressure syringe pump (Harvard 
Apparatus).  Prior to each experiment, the device was also loaded with fibronectin (25 
µg/mL, Invitrogen) and kept at room temperature for 30 minutes to promote optimal cell 
adhesion. 
Gradient formation.  The concentration gradients across the microchannel were 
verified by infusing fluorescently-labeled solution (Fluorescein, Sigma Aldrich) from one 
inlet and an unlabeled solution from the other inlet of the device (Figure 2.2).  Diffusive 
mixing across the interface of the laminar streams led to formation of the gradient.  
Fluorescent images were acquired at different locations along the channel using a FITC 
filter on the Zeiss Axiovert 200M microscope.  ImageJ was then used to analyze the 
fluorescence intensity profiles.  The plotted profiles confirm the formation of a well-
defined, linear and stable concentration gradient as also reported in similar works [65]. 
Primary neutrophil isolation.  Sodium Heparin (Fisher Scientific) anti-
coagulated human blood was obtained from healthy volunteers according to approved 
University of Illinois at Urbana-Champaign Institutional Review Board (IRB) protocol 
12030.  Written consent was obtained from all participants prior to any blood draw 
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according to the consent procedure approved by the IRB.  Neutrophils were isolated by 
density gradient centrifugation of a centrifuge tube containing 4 mL of whole blood 
layered over 4 mL of Cell Isolation Medium (Cedar Lane Labs).  The isolated 
neutrophils were washed twice and resuspended to 107 cells/mL in Hank’s Balanced 
Salt Solution with 2% Human Serum Albumin and incubated at 37ºC following a 
previously reported protocol [66]. 
Cell preparation.  Cells were washed and suspended in modified Hank’s 
Balanced Salt Solution (mHBSS) containing 1% Human Serum Albumin (HSA).  The 
device was prepared by washing the channels with a 70% v/v ethanol solution.  The 
channels were then rinsed with PBS (phosphate buffered saline) and 30 μL of the 
neutrophil suspension (5 x 106 cells/mL) was injected into the microfluidic device.  The 
device was next incubated for 20 minutes to allow cells to adhere to the substrate.  After 
incubation, the device was connected to a syringe pump and the desired combination of 
chemoattractant solutions (IL-8 and fMLP Sigma Aldrich, LTB4 Fisher Scientific) were 
infused into the device from separate inlets at a flow rate of 0.02 mL/hr to establish the 
desired concentration gradients. 
Time-lapse microscopy and analysis.  Upon visual confirmation of a stable 
gradient, differential interference contrast (DIC) images were captured with a Zeiss 10X 
NA 1.30 DIC objective on a Zeiss Axiovert 200M microscope every 10 seconds.  All 
images were captured with a cooled charge-coupled device camera (AxioCam MR3, 
Zeiss).  Cells were then randomly selected from the image stack and manually tracked 
using ImageJ® (NIH) using the Manual Tracking plugin by Fabrice Cordelieres (Institut 
Curie, France).  The plugin provided a way to tabulate the XY coordinates of each cell 
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centroid in the temporal stack, as well as to obtain velocity and displacement 
measurements between successive frames.  The resulting excel spreadsheets were 
then analyzed using custom Python scripts to yield cell trajectories, chemotactic indices, 
cell speeds and mean square displacements.  We define the chemotactic index (CI) as 
displacement along the gradient direction (x) over the total migration distance (d), or CI 
= x/d, while the mean square displacement is defined as: MSD =〈| ( )   ( )| 〉. 
Detailed description of neutrophil model.  Our model is based on a 
pseudopod-based model previously developed by van Haastert [38,52].  Cell motion is 
modeled as a correlated random walk (Δt = 20 seconds), where each time step 
corresponds to the next pseudopod generated.  Following van Haastert, we assume 
that the next pseudopod is generated either by splitting off from an existing one in a 
direction biased by the external chemoattractant gradients or by de novo pseudopod 
formation, where the new pseudopod is generated in an entirely random direction (see 
below for further details).  Where this model differs from previous ones is that we 
account for multiple chemoattractants and include an autocatalytic feedback loop that 
enables the cells to lock onto one chemoattractant while ignore the other. 
In the case of two intermediate chemoattractants, denoted by A and B, we 
assume the target direction of the cell  n  is determined by the weighted sum of the 
associated chemoattractant gradients: 
 
n = m
A
ÑL
A
+m
B
ÑL
B
 
where 
 
L
i
denotes the concentration for chemoattractant i and 
 
m
i
the associated weights 
(Figure 2.3).  The values for the weights are determined by the following set of 
differential equations 
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 denotes the amplified response to chemoattractant i and is given by the 
expression 
     (        
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where χi is chemotaxis coefficient for chemoattractant i and the 
 
k
amp
 is the amplification 
gain.  This functional form was chosen so that 
 
m
A
 and 
 
m
B
 sum to one and to provide a 
simple mechanism for hysteresis.  As shown in Figure 2.4, 
 
m
A
 dominates (i.e. mA ≈ 1) 
when χA is larger than χB, and vice versa.  In other words, this mechanism enables cells 
to lock onto one chemoattractant signal while ignoring the other.  Such a mechanism, 
we believe, provides the simplest explanation for the observed oscillatory motion in 
competing gradients of chemoattractants.  While there are a number of mechanisms 
that could give rise to this behavior, including the excitable networks previously 
proposed for eukaryotic chemotaxis [42,47], we chose to focus on a simple 
phenomenological model known to exhibit switch-like behavior as the molecular details 
governing chemotaxis to multiple gradients are still unknown.  
The chemotaxis coefficient χi determines how strongly the cells are biased in the 
direction 
 
ÑL
i
.  We assumed that the chemotaxis coefficient is given by the expression 
   
    
(       )
  
where the 
 
k
d ,i
 denotes the dissociation constant for the chemoattractant i. Note that if 
the fraction of bound receptors for chemoattractant i is given by 
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+ L
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then 
          
In other words, the cells move in the direction where the number of bound receptors on 
their surface is greatest.  Implicit in this formulation is the assumption that each 
chemoattractant binds a distinct receptor type and that there is no crosstalk between 
these receptors. 
The directional bias φ of splitting pseudopods is given by the expression 
  (    )    
where θ denotes the current direction of the pseudopod.  The difference is taken to be 
the minimal distance on the periodic domain θ ϵ (-π,π).  This aspect of the model 
coincides with compass-based theories in which an intracellular compass dictates the 
subsequent direction of motion. 
Following van Haastert, we simulate cell motion by assuming that the direction of 
the newly split pseudopod is given by  
                (   ) 
where ω = 0.25 denotes the extent to which a pseudopod can split in a given step.  
Again, following the Van Haastert model, we also incorporate additional randomness by 
allowing variability in the new pseudopod direction. In our model, we sample θ’split from a 
von Mises distribution whose mean is the new target direction θsplit and variance is 20°.  
The position of the cell is then updated using the following set of equations 
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We also assumed that de novo pseudopods are formed with a probability  s = 0.1 at each 
time step.  If such occurs, the new direction of the cell is given by 
                         
                         
where θde novo = rand(-π,π). 
We can readily extend the model to account for chemotaxis in opposing 
gradients of end-target chemoattractants such as fMLP and intermediate 
chemoattractants such as IL-8 and LTB4 by modifying the sensitivity equations as 
follows 
 
S
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where the subscripts A, B, and C denote fMLP, IL-8, and LTB4, respectively.  The 
parameter 
 
i
A
 is the strength of inhibition and set equal to 10 in our simulations.  Note 
that 
 
S
B
 and 
 
S
C
 are inhibited when the concentration of the end-target chemoattractant, 
denoted by A, is high.  The remaining equations are similar to as before: 
 
f
i
= S
i
1+ k
amp
m
i
2( ) 
and 
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The response vector is given by 
 
n = m
A
ÑL
A
(x)+m
B
ÑL
B
(x)+m
C
ÑL
C
(x) 
Otherwise, the model is identical.  As can be seen in Figure 2.5, this extension enables 
us to recapitulate the experiments involving opposing gradients of fMLP and IL-8 or 
LTB4. 
The primary justification for this model is that it supports our experimental 
observation. In particular, the model captures the oscillatory motion of the cell in 
opposing gradients of chemoattractants.  While the true mechanism may be different 
than the one proposed here, our simple model still allows cells to sequentially lock on to 
targets as they migrate within opposing linear gradients.  In the absence of such a 
mechanism, cells are predicted to migrate to a position equidistant between the two 
sources (Figure 2.6).  Our model is in close agreement with existing models in the 
literature, albeit it at the phenomenological level, which suggest that an excitable 
system could explain many aspects of cell behavior, including spontaneous polarization, 
adaptation, and the high degree of signal amplification seen in cells [67,68].  In our 
particular example with two stimuli, this type of thresholding mechanism gives rise to an 
ultrasensitive, ”winner-take-all” type switch that is robust and yields similar amplitude 
irrespective of initial position, as observed experimentally (Figure 2.7). 
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2.3. Results 
Chemotaxis in single chemoattractant gradients.  We first analyzed 
chemotaxis toward single gradients of fMLP, IL-8, and LTB4 by measuring the 
chemotactic index and average linear velocities using a microfluidic platform [13].  In the 
microfluidic platform, the concentration profiles established were linear across the 
channel width with small deviations from linearity at each end of the channel, as can be 
seen in Figure 2.2.  In each case, linear concentration profiles of 0-10 nM, 0-25 nM and 
0-50 nM were applied across the 350 μm channel, with no gradient as the control.  
These conditions were chosen roughly for their ability to produce optimal chemotaxis.  
As evidenced by the positive mean chemotactic indices in Figure 2.8, most cells 
exhibited net migration up each chemoattractant gradient.  However, in each case, the 
mean response varied according to the gradient condition with no obvious trend.  While 
the chemotactic index has previously been shown to correlate weakly with the slope of 
the gradient [25,32], we found that the cells were most responsive to fMLP in the 0-10 
or 0-25 nM range.  For IL-8, cells responded optimally to the 0-25 nM gradient.  Finally, 
for LTB4, cells were most responsive to the 0-50 nM gradient.  The linear velocities of 
these cells, however, did not exhibit any trends.  In particular, the slope of the gradient 
does not directly correlate to the linear velocity.  In addition, we also analyzed cell 
migration in isotropic environments (Figure 2.9).  We found that cells exhibit motion 
resembling persistent random walk as seen previously [33].  Overall, the chemotactic 
responses toward the single chemoattractant gradients were similar to previous reports 
[24,25,27,28,31,32,34,35]. 
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Response to single gradients superimposed over an alternate isotropic 
attractant field.  To study the effect of crosstalk on chemotaxis, a single gradient of one 
chemoattractant was established over a uniform field of another.  In the first case, an 
fMLP gradient was applied over uniform fields of IL-8 and LTB4, respectively.  As shown 
in Figure 2.10A, we found that increasing the background chemoattractant 
concentrations does not inhibit chemotaxis up the fMLP gradient in either case.  This is 
in agreement with previous findings, where cells have been shown to migrate up end-
target attractant (fMLP) gradients over other intermediate attractant fields [24,25,28,31].  
In the second case (Figure 2.10B), single gradients of the intermediate 
chemoattractants LTB4 and IL-8 were established over a uniform concentration of fMLP.  
We found that increasing the concentration of fMLP inhibited chemotaxis up either 
intermediate attractant gradient.  Together with the previous result, this observation 
corroborates the existence of a signaling hierarchy between the two classes of 
chemoattractants, in which fMLP takes precedence over both IL-8 and LTB4 as 
previously described [31].  In the third case (Figure 2.10C), a single IL-8 gradient was 
established over a uniform concentration of LTB4, and vice versa.  In this case, a 
negative correlation can be noted between the background concentration and 
chemotactic index, where the background attractant field appears to inhibit migration up 
the gradient of the alternate intermediate chemoattractant.  These results suggest that 
neither attractant takes precedence over the other in terms of a strong signaling 
hierarchy - instead, both species appear to attenuate the chemotactic efficiency toward 
the other in a relatively symmetric fashion. 
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Oscillatory behavior in opposing intermediate attractant gradients.  We next 
explored chemotaxis in opposing linear gradients of IL-8 and LTB4.  In these 
experiments, the cells were tracked for up to 80 minutes to analyze their individual 
behavior.  The representative trajectories of cells under varying gradient conditions are 
shown in Figures 2.11 and 2.12.  The first thing to note is that in almost all cases, cells 
initially migrated against the local gradient of the proximal source to display "true" 
chemotaxis toward the distant agonist.  That is, cells initially positioned in the upper half 
of the channel appeared to move toward the lower half and vice-versa, as previously 
documented [25,35].  Over longer times, however, we note that these cells then 
undergo multiple directional changes, resulting in oscillatory trajectories meandering 
back and forth between the two maxima.  Again, while it was previously speculated that 
cells would move in this manner [35], this is the first experimental confirmation of this 
hypothesis. 
To demonstrate that the oscillations occur only when two gradients are present, 
we compared the trajectories in isotropic, single gradient, and dual gradient cases 
(Figure 2.13).  Unlike the cell trajectories in the uniform IL-8 environment, in which 
displacement along the channel width fluctuated around the initial starting position, the 
oscillations in the dual gradient case are centered around the middle of the channel.  
This dissemblance is further shown quantitatively in Figure 2.14, where we counted the 
average number of times the channel median was crossed by each cell.  Prior to 
counting, the data was first pre-processed using state estimation via a standard Kalman 
filter with process noise variance set to 10-4 microns2.  Here, we see that the mean 
number of zero crossings is higher in the dual gradient experiments than in the control.  
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Specifically, when both gradients are large (≥ 0-10 nM), the cells migrate across the 
center of the channel significantly more times than in either the single gradient or 
isotropic conditions.  This result implies that the cells oscillate between the two maxima.  
The large variance occurs because of the random starting location of the cells.  Still, this 
result suggests that the oscillatory behavior of cells in the opposing gradients is not the 
result of the random motion of migrating cells in isotropic conditions.  To determine if 
neutrophils can preferentially migrate to end-target chemoattractants, opposing 
gradients of fMLP vs. IL-8 and fMLP vs. LTB4 were established in the microchannel.  
Cell migration under varying conditions is shown in Figure 2.15 where the cells migrate 
up the fMLP gradient as seen previously [24,25]. 
Feedback-based model for neutrophil migration.  To further understand 
oscillatory motion in opposing gradients of intermediate chemoattractants, we explored 
a number of different mathematical models of neutrophil chemotaxis.  These models 
were phenomenological in the sense that they capture only the behavioral response of 
neutrophils and ignore the governing signal transduction pathways.  Analysis of these 
models indicates that sensory adaptation alone may be insufficient to generate 
oscillatory motion in linear gradients.  In particular, no single choice of parameters 
would sustain oscillations over linear gradients of varying magnitude.  Moreover, these 
models predict that the amplitude is dependent on the initial position of the cells 
contrary to what we observe experimentally.  Finally, they all predict that the oscillations 
will decay exponentially, also contrary to what we observe albeit over the time course of 
our experiments.  Therefore, we considered alternate mechanisms. 
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One simple mechanism that would explain the oscillations is to assume that 
neutrophils selectively lock onto one chemoattractant while ignoring the other.  Such a 
mechanism could arise if the signaling pathways employ positive feedback (Figure 
2.16), as is known to occur in neutrophil chemotaxis [36,37].  Assuming that these 
feedback loops are competitive, then the result would be a hysteretic switch that 
enables cells to lock onto specific chemoattractant gradients while ignoring others 
(details provided in the Materials and Methods section).  Note, this mechanism can be 
viewed as a form of sensory adaptation, albeit in a competitive form.  We tested this 
mechanism by extending a model previously developed by Van Haastert et al. [38-40] 
for chemotaxis towards a single chemoattractant.  Application of this model to various 
experimental conditions, including (i) an isotropic chemoattractant environment, (ii) a 
single chemoattractant gradient, (iii) a single chemoattractant peak (or “hill gradient”), 
and (iv) dual opposing intermediary chemoattractant gradients, produces simulated cell 
trajectories that are qualitatively consistent with experimental results, as shown in 
Figure 2.17.  While this mechanism is still speculative, it nonetheless supports the 
hypothesis that neutrophils make specific choices when given a menu of options. 
2.4. Discussion 
Neutrophil chemotaxis is an important physiological process that occurs during 
immune defense and wound healing.  During this process, neutrophils encounter 
chemoattractants emanating from multiple sources resulting in a complex milieu of 
conflicting chemoattractant gradients.  More specifically, on the surface of the 
endothelium neutrophils are presented with opposing gradients of intermediate 
chemoattractants [21-23].  There, the cells must migrate away from the endothelial-
35 
derived attractant toward the source of other tissue-derived intermediate 
chemoattractants [41].  These cells must efficiently navigate through the 
chemoattractant landscape to reach the site of infection.  However, the chemotactic 
response to multiple attractant sources remains poorly understood [1-3].  In this chapter, 
we applied a microfluidic device to study the behavior of primary cells under opposing 
gradients of the intermediate chemoattractants LTB4 and IL-8.  Previous reports 
describe neutrophils seeking the distant source in opposing intermediate attractant 
gradients [25].  By increasing the length of the experiments we report, for the first time, 
neutrophils exhibiting oscillatory behavior between the two maxima.  In addition, the 
results corroborate previous reports of neutrophil responses in varying chemoattractant 
conditions [24,25], showing that: (i) the intermediate chemoattractants IL-8 and LTB4 do 
not inhibit the response toward the end-target chemoattractant fMLP (indicating that the 
latter takes precedence in an intracellular signaling hierarchy), and that (ii) IL-8 and 
LTB4 have a weak inhibitory effect on one another, but their effect is mutual (suggesting 
that no hierarchy is present for these intermediate cues). 
While many models of neutrophil chemotaxis have been proposed [38-40,42-56], 
these models have largely focused on chemotaxis towards a single chemoattractant.  
Only a few models have explored network chemotaxis in presence of multiple 
chemoattractants.  In one notable study, Lin and coworkers developed a mathematical 
model based on sensory adaptation [54,57].  They showed that cells with desensitizable 
receptors could indeed exhibit preferential migration toward distant sources.  However, 
this model does not predict oscillatory motion.  Rather, their model predicts that the cells 
will migrate to a position equidistant between the two chemoattractant sources (in 
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dimensionless terms).  The reason this occurs is because the equidistant point is where 
both sets of receptors are equally desensitized.  A key difference in our model is that 
only one set of receptors is being deactivated while the other remains active.  Moreover, 
our model exhibits hysteresis which enables it to bypass the otherwise stable fixed point 
at the equidistant midpoint. 
In a second notable study, Oelz and coworkers suggested that the migrational 
bias towards the distant chemoattractant was due to the cells’ inability to rapidly adjust 
their sensitivities [55].  By allowing for dynamic sensitivities, their model predicts that 
cells can oscillate back and forth between the two maxima under certain conditions.  
While this model predicts oscillatory movement, it does so for only exponential gradients 
and not linear ones.  In addition, their model predicts that the amplitude of the 
oscillations is determined by the starting position of the cells.  Our experimental results, 
on the other hand, suggest that the oscillatory response of cells is invariant to the phase 
or initial position of the cell in its trajectory.  The robustness of the sustained oscillatory 
response strengthens the argument for a feedback-based mechanism in which cells 
transiently lock onto sensed targets.  That said, their model provided the basis for our 
model. 
The switch-like behavior, predicted by our model (developed by Yuki Kimura and 
the Rao Lab), could be a function of positive feedback mechanisms in intracellular 
signaling pathways.  For instance, the lipid PtdIns(3,4,5)P(3) has been shown to 
stimulate its own accumulation by activating Rho GTPases, which in turn increase 
PtdIns(3,4,5)P(3) accumulation [36,37].  This positive feedback mechanism allows 
signals to be amplified and the cell to polarize and respond in the direction of the 
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strongest signal, allowing the cell to lock onto one chemoattractant gradient while 
ignoring others.  A similar mechanism occurs during actin polymerization, where 
neutrophils responding to chemotactic stimuli increase the nucleation and 
polymerization of actin filaments in the region receiving maximal chemotactic stimulation 
[58].  In addition, the switching mechanism does not appear to be a phenomenon 
exclusive to chemotaxis in dual intermediate chemoattractant gradients.  In the 
presence of both end target and intermediate chemoattractants, PTEN prioritizes these 
cues switching from the PI(3)K pathway towards a p38 MAPk pathway [26].  The 
process of switching between the two pathways allows the cells to prioritize and 
integrate responses to multiple chemotactic cues.  In addition, recent discoveries have 
shown that in vivo, different chemoattractants may collaborate sequentially in temporal 
and spatial cascades to choreograph neutrophil recruitment [4,59].  The requirement for 
particular chemoattractant types at specific steps in this process could involve unique 
temporal and/or spatial patterns of chemoattractant expression, but the corresponding 
sensory mechanism in migrating cells could be achieved through this switch-like 
response, in which multiple signals could be prioritized through internally designated 
response thresholds. In another recent study, neutrophil chemotaxis has been shown to 
be regulated by bidirectional regulation of distinct ‘stop’ and ‘go’ signals [60].  The cell 
can dynamically switch between the two signals to tightly regulate migration.  Further, 
two-photon imaging of neutrophil chemotaxis in zebrafish showed that retrograde 
chemotaxis of cells away from the site of inflammation may also play an important role 
in inflammatory resolution [61-63].  The ability of cells to lock on and off of target cues 
may be central to this process, by allowing cells to move between different locations 
38 
through tight regulation.  Overall, these studies suggest a switch-like mechanism may 
help to regulate cell migration and find their end target. 
In the context of physiological environments, particularly in the extravascular 
space, the consequences of a switch-like chemotactic response and migration toward 
distant intermediate attractant sources remain unclear.  One hypothesis, in line with that 
proposed by Foxman et al. [35], is that this response might enable the cells to navigate 
long distances in a stepwise fashion between a network of intermediate chemoattractant 
sources, as a way to increase their chances of locating end targets.  In support of this 
hypothesis, recent discoveries by Lammermann and coworkers have shown that in vivo 
LTB4 acts as an intercellular signal relay molecule, where LTB4 amplifies local cell death 
signals and enhances the radius of highly directed neutrophil migration [64].  
Furthermore, defects in the generation of these intermediate chemoattractant gradients 
leads to ill-favored accumulation of neutrophils in tissue [4,59].  This guided homing 
mechanism may work to enhance the search efficiency of neutrophils when multiple 
stimuli are present, by using the sequential intermediate attractant sources for loose 
guidance en route to their destinations, as shown in Figure 2.18. 
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2.5. Figures 
 
Figure 2.1. Schematic of microfluidic platform with Y-shaped channel.  The 
platform was comprised of a molded PDMS slab embossed with microchannels and 
bonded to a glass coverslip. 
 
 
Figure 2.2. Cross-sectional concentration profile for single gradient.  Gradient 
formation was verified by feeding a fluorescein-labeled solution into one inlet and an 
unlabeled solution into the other inlet of the device.  The resulting fluorescence intensity 
profile confirms the formation of a well-defined, stable, linear concentration gradient.  
The normalized FITC concentration across the channel cross-section is shown. 
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Figure 2.3. Schematic of proposed mechanism for signal discrimination.  The 
response toward each chemoattractant is autocatalyzed in a nonlinear fashion, where 
 
m
A
 and 
 
m
B
 denote the normalized response to each attractant. 
 
 
 
Figure 2.4. The signaling threshold mechanism.  [Left] Response as function of 
 
S
A
 
and 
 
S
B
 (
 
k
amp
= 20).  Note the hysteresis in the response – this is necessary to generate 
the oscillations that results from the overshoot inherent in this mechanism.  [Right] 
Response as a function of amplification gain parameter 
 
k
amp
 when 
 
S
A
/ S
B
=1. 
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Figure 2.5. Simulation of the model in a competing gradient of an end-target 
chemoattractant and intermediate chemoattractant.  The parameter values used in 
this simulation are:  v = 0.3  μm/s, kd,j = 10
-8 M, kd,A = 10
-8 M, 
 
k
amp
= 20 , 
 
i
A
=10, LA (x) = 
10-8(1-x/350) M (end-target), and LB (x) – 10
-8(x/350-1) M (intermediate). 
 
 
Figure 2.6. No oscillations are observed in the absence of pseudopod memory.  In 
these simulations, 
 
m
A
 and 
 
m
B
 are fixed at the value 1.0.  The parameter values used in 
this simulation are:  v = 0.3  μm/s, kd,j = 10
-8 M, LA (x) = 10
-8(1-x/350) M, and LB (x) – 10
-
8(x/350-1) M. 
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Figure 2.7. The model is able to robustly generate sustained oscillatory behavior.  
The initial position of the cells does not affect the amplitude of the oscillatory motion.  
The parameter values used in this simulation are:  v = 0.3  μm/s, kd,j = 10
-8 M, 
 
k
amp
= 20 , 
LA (x) = 10
-8(1-x/350) M, and LB (x) – 10
-8(x/350-1) M. 
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Figure 2.8. Chemotaxis in single attractant gradients.  [A] Chemotactic indices in 
single attractant gradients.  Neutrophils migrated toward higher concentration in all 
single linear attractant gradients, as indicated by the positive chemotactic indices.  In 
each experiment, 30 cells were tracked for 20 minutes.  [B] Average linear velocities of 
the cells from the single attractant gradient experiments.  
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Figure 2.9. Migration in isotropic attractant conditions.  [A] Uniform chemoattractant 
environments were established by introducing the same solution into both channel 
inlets.  Cells were tracked for 20 minutes in fMLP, IL-8 and LTB4, and the upward 
migration indices of 30 cells are shown here for comparison against the control (MHBSS 
buffer only).  [B] The mean square displacements (MSD) of the cells from the previous 
figure as a function of time.  Cells were exposed to uniform concentrations of fMLP, IL-8 
and LTB4.  [C] The average linear velocities of the cells from the previous figure.  Again, 
cells were exposed to uniform concentrations of fMLP, IL-8 and LTB4.  [D] Sample 
trajectories from the previous control experiments. [top left] MHBSS buffer only; [top 
right] 25nM fMLP; [bottom left] 25nM IL-8; [bottom right] 50nM LTB4. 
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Figure 2.10. Chemotaxis in single gradients superimposed over isotropic 
attractant field.  [A] Chemotactic index in a 0-25nM fMLP gradient over uniform 
intermediate chemoattractant concentration.  The fMLP gradient was fixed for all 
conditions, while the concentration of the uniform intermediate attractant background 
was varied from 0 to 10 nM for both IL-8 and LTB4. 30 cells were tracked for 20 minutes 
for each experiment.  [B] Chemotactic index in 0-25nM IL-8 and 0-15nM LTB4 gradients 
over uniform fMLP.  All conditions in the left figure consisted of a fixed 0-25nM IL-8 
gradient over a uniform fMLP field, while all conditions on the right had a fixed 0-15nM 
LTB4 gradient over uniform fMLP. 30 cells were tracked for each experiment.  [C] 
Chemotactic indices for cells in intermediate chemoattractant gradients over uniform 
background concentration of alternate intermediate chemoattractant.  All conditions in 
the left figure consisted of a fixed 0-15nM IL-8 gradient over a varying uniform LTB4 
background, while all conditions in the right figure consisted of a fixed 0-25nM LTB4 
gradient over a varying uniform IL-8 background. 
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Figure 2.11. Sample cell trajectories in dual opposing intermediate 
chemoattractant gradients.  Representative cell trajectories indicating the migration 
behavior of cells in dual opposing gradients of IL-8 and LTB4. 
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Figure 2.12. Aligned sample trajectories in dual opposing intermediate 
chemoattractant gradients.  As a visual guide, the cell trajectories from Figure 2.19 
were aligned based on the farthest each cell migrated towards the IL-8 source (denoted 
zero time). 
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Figure 2.13. Sample cell trajectories under varying intermediate chemoattractant 
conditions.  Representative cell trajectories indicating the migration behavior of cells in 
[A] isotropic conditions, [B] single gradients, and [C] dual opposing gradients of IL-8 and 
LTB4.  
 
 
Figure 2.14. Oscillatory behavior based on zero crossings.  The cell trajectories 
were analyzed to count the number of times the channel centerline was crossed within 
each 80 minute experiment.  Noise was attenuated using state estimation via a 
standard Kalman filter with process noise variance set to 10-4 microns2.  The first two 
columns on the left represent the single gradient controls for IL-8 and LTB4 respectively.  
P-values relate to single gradient controls, where * represents statistical significance 
compared to isotropic conditions (p < 0.05).  Statistical significance was determined 
using a one-tailed Welch’s t-test of unequal variance on the data. 
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Figure 2.15. Chemotaxis in opposing linear chemoattractant gradients with fMLP.  
Chemotactic index in a 0-25 nM fMLP gradient versus varying IL-8 and LTB4 gradients.  
The fMLP gradient was fixed for all conditions, while the intermediate attractant gradient 
was varied from no gradient to 0-100 nM for both IL-8 and LTB4. 30 cells were tracked 
for 40 minutes for each experiment.  The correlation with the intermediate 
chemoattractant gradient was weak with Pearson correlations (r. -0.1694; P. 0.1331) 
and (r. -0.1304; P. 0.1785), respectively. 
 
 
 
Figure 2.16. Schematic of proposed mechanism governing oscillatory motion.  
Oscillatory behavior results from the amplification of the response toward the distant 
chemokine source, while inhibition of the opposite signal results in the switch-like 
behavior.  The variables 
 
f
A
 and 
 
f
B
 denote the positive feedback loops governing the 
switch behavior. 
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Figure 2.17. Comparison of theoretical and experimental neutrophil responses to 
varying conditions.  [A] Cell trajectories along the channel width in our microfluidic 
experiments, under isotropic (25 nM IL-8), single linear gradient (0-25 nM IL-8), single 
hill-type gradient (0-25-0 nM IL-8), and dual opposing gradients of 150 nM LTB4 and 
100 nM IL-8, respectively.  The hill-type gradient was established using a three-inlet 
device with a similar design to the “Y-shaped” device.  Confirmation of the concentration 
profile is shown in Figure S6.  [B] Simulated cell positions along the channel width 
obtained from our feedback-based model, when applied to the corresponding 
chemoattractant conditions.  The qualitative behaviors are similar. The parameter used 
for the simulation are:  v = 0.3  μm/s, kd,I = 10
-8 M, kd,A = 10
-8 M, and 
 
k
amp
= 20 . 
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Figure 2.18. Simulation of stepwise navigation through multiple chemoattractant 
sources.  Gray lines denote the trajectories of individual cells.  Red and blue lines 
denote the contours for Gaussian concentration profiles for intermediate 
chemoattractant sources and the green lines denote the contours for an end-target 
chemoattractant source (positioned in the center of the plot).  Note the cells migrate 
between intermediate sources of chemoattractants before converging on the final end 
target.  The parameter values used in this simulation are: v = 0.3 μm/s, kd,I = 10
-8 M, 
k
amp
= 20 , and i
A
=10. All chemoattractant sources were modeled as Gaussians:  
 (   )          (    ((    )  (    ))) 
where σ2 = 20,000 μm2 and xi ,yi( )denote the position of the source. 
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Figure 2.19. Cross-sectional concentration profile for hill-type gradient.  Gradient 
formation was verified by feeding a fluorescein-labeled solution into the central inlet and 
an unlabeled solution into the outer inlets.  The normalized FITC concentration across 
the channel cross-section is shown. 
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CHAPTER 3 
Chemotaxis around physical barriers 
3.1. Introduction 
During an infection, neutrophils are employed as the first line of defense against 
invading pathogens [1-3]. These cells sense and migrate up concentration gradients of 
chemical attractants in a process termed chemotaxis. To locate sites of infection or 
inflammation, neutrophils must efficiently navigate through a complex landscape of 
overlapping chemoattractant gradients and aligned extracellular matrix (ECM) fibers [4]. 
The alignment of these fibers can direct migration through a mechanism termed contact 
guidance [5-7]. However, the chemoattractant gradients and ECM fibers can, at times, 
be aligned in vectorially differing directions. Thus, neutrophils must employ some form 
of decision making process to optimize the migratory path toward the desired site. 
Previous work has demonstrated that neutrophil chemotaxis is retarded when 
chemotactic and contact guidance signals were presented perpendicularly [8]. These 
results demonstrate that for neutrophils, the mechanism of chemotaxis dominates over 
contact guidance. Still, the logic used to determine the optimal route to an end target is 
unclear. To address the issue, Ambravaneswaran and coworkers found that when 
presented with bifurcating channels of different lengths neutrophils will take the shortest 
path to reach the end target 90% of the time [9]. Further, at symmetric bifurcations with 
small posts, neutrophils split their leading edge, suggesting that some form of 
directional decision-making localized at the leading edge of the cellular cytoskeleton 
takes place. 
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In this chapter, a microfluidic platform with a barrier in the migration path to study 
the cellular decision making process that occurs during chemotaxis was developed. The 
chemoattractant concentration across the width of the barrier was found to not 
significantly vary, providing a large bifurcation in the migratory path of the differentiated 
HL-60 cells. These differentiated leukocytes have been proven as a valid model system 
of neutrophil chemotaxis [10]. By analyzing chemotaxis around the patterned barriers, 
cells were found to efficiently migrate around 40-µm and 100-µm wide barriers. Further, 
neutrophils became less efficient migrating around 200-µm wide barriers due to 
decreased persistence lengths. 
3.2. Materials and methods 
Microfluidic device fabrication. The microfluidic device was fabricated out of a 
molded poly(dimethylsiloxane) (PDMS, General Electric RTV 650 Part A/B) slab bonded 
to a glass substrate, as reported previously [11,12]. The designed pattern was printed 
via high resolution printing (5080 dpi) on a transparency film to create a mask. The 
design was patterned into 50 µm high SU-8 2050 photoresist (Microchem) via 
photolithography by placing the mask on a coated silicon wafer and exposing the setup 
to ultraviolet light [13-15]. PDMS molds with embossed channels were fabricated using 
soft lithography by curing the pre-polymer on the silicon master for 2 hours at 70ºC [16]. 
The PDMS replica was then peeled off the silicon master. Inlets and outlets for the fluids 
and cells were created in PDMS using a steel punch. The surface of the PDMS replica 
and a clean glass coverslip (Fisher Scientific) were treated with air plasma for 90 
seconds (Model PDC-001, Harrick Scientific) and irreversibly bonded to complete the 
device assembly (Figure 1). The device inlets were then connected to 1 mL syringes 
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(BD Biosciences) with 23 G ¾ size needles (BD Biosciences) via PTFE tubing (Cole-
Parmer). All syringes were calibrated and actuated by a constant pressure syringe 
pump (Harvard Apparatus). Prior to each experiment, the device was also loaded with 
fibronectin (25 µg/mL, Invitrogen) and kept at room temperature for 30 minutes to 
promote optimal cell adhesion. 
Cell culture, differentiation, and preparation. HL60 cells were cultured at 37 
°C with 5% CO2 in RPMI 1640 (Sigma Aldrich, St. Louis MO) with 10% FBS, 
penicillin/streptomycin, and 25 mM HEPES. Cells were differentiated by addition of 
1.3% DMSO for 6 days [17]. Prior to experimentation, differentiated cells were pelleted 
and resuspended in mHBSS (Invitrogen, Carlsbad, CA, USA) with 1% Human Serum 
Albumin (HSA). All experiments were performed in mHBSS with 1% HSA. The device 
was prepared by washing the channels with a 70% v/v ethanol solution. The channels 
were then rinsed with phosphate buffered saline (PBS) and 30 μL of the cell suspension 
(5 x 106 cells/mL) was injected into the microfluidic device. The device was next 
incubated for 20 minutes to allow cells to adhere to the substrate. After incubation, the 
device was connected to a syringe pump and a combination of mHBSS and 
chemoattractant solutions (fMLP Sigma Aldrich) were infused into the device from 
separate inlets at a flow rate of 0.02 mL/hr to establish the desired concentration 
gradients. 
Time-lapse microscopy and analysis. Upon visual confirmation of a stable 
gradient, differential interference contrast (DIC) images were captured with a 10X NA 
1.30 DIC objective on a Leica DMI 400b microscope every 10 seconds. All images were 
captured with a cooled charge-coupled device camera (Hamamatsu ORCA-ER). Cells 
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were then randomly selected from the image stack and manually tracked using 
ImageJ® (NIH) using the Manual Tracking plugin by Fabrice Cordelieres (Institut Curie, 
France). The plugin provided a way to tabulate the XY coordinates of each cell centroid 
in the temporal stack, as well as to obtain velocity and displacement measurements 
between successive frames. The resulting excel spreadsheets were then analyzed to 
yield cell trajectories, chemotactic indices, cell speeds and mean square displacements. 
3.3. Results 
Measuring concentration within the microfluidic platform. To investigate the 
decision making process during neutrophil migration around physical barriers, a 
microfluidic platform was employed (Figure 3.1). Microfluidic platforms are well suited to 
study neutrophil chemotaxis due to the ability to control the chemical microenvironment 
[18]. Specifically, these platforms enable the generation of stable, rapidly established 
chemoattractant concentration gradients [19,20]. In the microfluidic platform employed 
here, the channels form a ‘Y-shape’, enabling generation of stable, linear chemical 
concentration gradients [20]. Neutrophils placed in the microchannel migrate up the 
chemical concentration gradient during chemotaxis. As part of the main PDMS slab, the 
barriers are comprised of PDMS and were designed in the center of the main channel of 
the platform. The patterned barriers are 40-µm, 100-µm, and 200-µm wide, and provide 
an obstacle which the cells must migrate around. 
With the desire to examine the decision making process of neutrophils during 
chemotaxis, the concentration across the width of the barrier must remain constant in 
order to provide an unbiased bifurcation. Thus, the concentration across the width of 
each barrier was characterized by both experimental measurement and computational 
63 
simulations to ensure that the barriers act as an unbiased bifurcation. A computational 
model of the microfluidic platform was developed in Comsol, a finite element analysis 
software package. The computational simulations enable prediction of the chemical 
concentration within the microchannels. Using the computational model, the 
concentration stays nearly constant across the width of barriers 40-µm, 100-µm, and 
200-µm wide (Figure 3.2). To supplement the computational simulations, experimental 
measurements of concentration were performed. The measurements were performed 
by infusing a fluorescently-labeled solution from one inlet and an unlabeled solution 
from the other inlet of the device. Diffusive mixing across the interface of the laminar 
streams led to formation of a gradient, enabling concentration measurements across the 
width of the barrier. The concentration across the width of all barriers was found to be 
consistent (Figure 3.2). The experimental measurements also demonstrated a constant 
concentration across the width of all barriers, in agreement with the computational 
simulations. Thus, the barriers patterned into the microfluidic platform provide an 
unbiased bifurcation in the path of the neutrophil migration. 
Cell migration trajectories. Chemotaxis around a barrier was analyzed by 
tracing the cell trajectories (Figure 3.3). In the microfluidic platform, a concentration 
gradient of 0-25 nM fMLP was established across the 350 µm channel. This condition 
was chosen due to the ability to produce a strong chemotactic response. Cells migrated 
up the chemical concentration gradient and collided with a 40-µm, 100-µm, or 200-µm 
wide barrier. Upon collision, the cells were confronted with a bifurcation in their 
migratory path and migrated either left or right around the barrier. After migrating around 
the barrier, the cells continued migrating up the concentration gradient. The response 
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demonstrates the ability of the cells to chemotax either direction around the barriers. 
Further, collision with the barrier does not interfere with the neutrophils ability to migrate 
afterward. 
Analysis of cell migration around barriers. The neutrophil trajectories were 
analyzed to determine which direction the cells migrated around the barrier (Figure 
3.4a). The neutrophils migrated left around the barrier 46% of the time, whereas they 
migrated to the right 54% of the time. The angle at which the cells approached the 
barrier immediately prior to collision was quantified to determine if the angle affected the 
direction chosen (Figure 3.4b). If the cells chemotax directly up the channel, migrating 
perpendicular to the face of the barrier, the angle is quantified as 0°. Further, if the cells 
are migrating directly from the left to the right, the angle is quantified as 90°. Similarly, if 
the cells are migrating directly from the right to the left, the angle is quantified as -90°. 
After quantifying the angle at which the neutrophils contacted the barrier, these angles 
can be compared to the direction the cells migrated around the barrier (Figure 3.4c). 
The angle at which the neutrophils contacted the barrier strongly correlated with the 
direction taken around the barrier. This observation is in agreement with directional 
persistence. However, a small fraction of the cells deviated from the noted correlation 
between angle of incidence and direction chosen. 
Quantitative analysis of neutrophil migration after contact with a barrier. To 
determine what caused those cells to deviate from the noted correlation between angle 
of incidence and direction chosen, the percentage of cells changing migration direction 
after contacting the barrier was quantified (Figure 3.5a). The number of cells changing 
direction increased as barrier width increased. This is increase in the number of cells 
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changing direction is expected, as the cells must migrate a longer distance to reach 
directed migration (chemotaxis) in the 200 µm barrier condition. 
The change in migration direction was further explored by quantifying the number 
of directional changes in only those cells that changed direction (Figure 3.5b). The 
number of changes in direction increased as the barrier width increased. The increased 
number of directional changes affects the cells ability to efficiently migrate around the 
barrier. To further asses the ability of the neutrophils to efficiently chemotax around the 
barrier, the distance the neutrophils migrated before changing direction, the persistence 
length, was quantified (Figure 3.5c). The persistence length decreased as the number 
of directional changes increased. This implies that with each change in direction, the 
cell becomes less efficient when trying to migrate around the barrier. Overall, these 
results show that neutrophils can migrate around barriers of varying sizes, but the 
efficiency is affected. 
3.4. Discussion 
Neutrophils play an important role in the innate immune response [3,21]. To locate the 
site of infection or inflammation, neutrophils must migrate through a complex milieu of 
chemoattractant gradients and around aligned ECM fibers. While neutrophils have previously 
been shown to prioritize chemotaxis over contact guidance, the directional decision making 
process that occurs while migrating around these ECM fibers is still unclear [8]. In this chapter, 
a microfluidic platform was employed to study the behavior of neutrophils while migrating 
around barriers. The chemoattractant concentration across the width of the barriers was found 
to remain constant. The constant chemical concentration provided a symmetric bifurcation in the 
neutrophil migration path. Neutrophils were able to efficiently migrate around 40-µm and 100-
µm wide barriers. However, neutrophils became less efficient migrating around 200-µm wide 
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barriers due to decreased persistence lengths. Further, the direction take to migrate around the 
barriers was highly dependent upon the angle at which the cells contacted the barrier. 
Directed cell migration, such as chemotaxis, occurs when actin-rich protrusion, termed 
pseudopods, maintain the orientation of the leading edge of cells [22-25]. Over short time and 
length scales, neutrophils are able to maintain these pseudopods enabling directed migration 
[24,26]. The persistence of these pseuopods has been found to positively correlate with 
directional persistence [27]. This mechanism of directional persistence agrees with our 
observations that neutrophils can efficiently migrate around the 40-µm and 100-µm wide 
barriers. Further, the observed correlation between migration direction and contact angle 
supports the hypothesis that directional persistence provides these cells a mechanism of short 
distances to search for an optimum. 
The tortuous, inefficient navigation that occurred when the neutrophils were migrating 
around 200-µm wide barriers is likely due to a deviation from directional persistence. Over long 
time and length scales, directional persistence is insufficient in providing neutrophils an efficient 
route when in the absence of a directed stimulus (e.g., chemical concentration gradient) [24]. 
When directed migration breaks down, random generation of pseudopods causes neutrophils to 
change direction more frequently [28,29]. This random generation of pseudopods may, at times, 
increase the sampling space of cells, enabling a more extensive search for a local maximum. 
However, in this engineered situation the neutrophils became less efficient as the randomly 
generated pseudopods were stabilized causing the cells to change direction. 
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3.5. Figures 
 
Figure 3.1.  Illustration of the microfluidic platform with physical barriers.  The 
barriers and channels are comprised of PDMS and bonded to a glass coverslip.  The 
barriers vary in size from 40-µm to 200-µm wide and provide a bifurcation in the path of 
neutrophil chemotaxis. 
 
 
 
Figure 3.2.  Concentration across the width of the physical barriers.  Experimental 
measurements were performed to determine the concentration across the width of 
barriers [A] 40-µm, [B] 100-µm, and [C] 200-µm wide.  The concentration was also 
computationally simulated across barriers [D] 40-µm, [E] 100-µm, and [F] 200-µm wide. 
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Figure 3.3.  Sample cell trajectories with varying barrier widths.  Representative 
cell trajectories indicating the migration behavior of cells migrating around barriers [A] 
40-µm, [B] 100-µm, and [C] 200-µm wide.  All experiments were repeated eight times 
resulting in at least 50 cells analyzed for each condition. 
 
 
 
 
 
Figure 3.4.  Analysis of migration direction around barriers.  [A] Percentage of cells 
going either direction around the barrier.  [B] Determination of the angle at which the 
cells collide with the barrier.  [C] Comparison of the angle of incidence and direction 
taken around the barrier.  Experiments were performed on barriers 40-µm, 100-µm, and 
200-µm wide and repeated eight times resulting in 175 cells analyzed. 
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Figure 3.5.  Quantitative analysis of neutrophil migration after contact with a 
barrier.  [A] Percentage of cells changing direction while attempting to migrate around 
barriers 40-µm, 100-µm, and 200-µm wide.  [B] The number of directional changes 
during migration around barriers.  [C] The distance cells migrate after contact with the 
barrier before changing directions.  All experiments were repeated eight times resulting 
in at least 50 cells analyzed for each condition.  Significant differences are labeled by 
asterisks (* P < 0.05). 
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CHAPTER 4 
Microfluidic platform to study intercellular signaling 
Ϯ 
4.1 Introduction 
Intercellular communication via soluble molecules is crucial for many biological 
processes, including stem cell proliferation and differentiation [1-3], tumorigenesis [4-8], 
development of drug resistance [8-10], as well as innate and acquired immune 
responses [11,12].  Hence, the ability to study cell-cell communication via chemical 
signaling is a critical need in the field of biology.  By allowing multiple cell populations to 
communicate in a controlled manner, systematic in vitro studies on how the cells would 
behave in vivo can be performed.  However, the ability to study these cell-cell 
interactions in a well-controlled three-dimensional (3D) environment is still limited. 
Microfluidic platforms that allow for precise control over cell seeding, cell culture, 
and the chemical microenvironment of cells have been developed to study intercellular 
communication [13-18].  Many of these studies are restricted to two-dimensional (2D) 
cell cultures, whereas 3D cell cultures are known to be more physiologically relevant 
[19-22].  Microfluidic platforms have also been developed to pattern cells in 3D 
constructs using laminar flow [23-25].  Specifically, these platforms were used to study 
cell migration under co-culture in 3D [26], and more pertinent to the research described 
here, to study intercellular communication in 3D between two cell types [27-30].  These 
3D platforms lack sufficient control over the diffusion and gradient formation of soluble 
molecules, and are often restricted in the allowable spacing between adjacent 
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microchannels.  As a result, mimicking the in vivo spatial and temporal characteristics of 
intercellular communication is challenging to capture, and the cellular systems that can 
be studied are limited.  These issues can be addressed by optimal design of a 
microfluidic platform and associated experimental conditions based on a detailed 
description of the effects of different parameters on intercellular communication. 
In this chapter, we developed a microfluidic platform, whose design was guided 
by modeling of diffusional mass transport of signaling molecules.  The platform was 
used to position one soluble molecule and two different cell types encapsulated in 
biologically-derived 3D scaffolds in adjacent channels.  Autocrine and paracrine 
signaling molecules can diffuse between these channels such that the patterned cells 
can communicate.  The diffusion of these molecules in the platform was modeled to 
determine optimal dimensions of the microchannels and the distance between them.  A 
proof of principle model system composed of lipopolysaccharide (LPS), mouse 
macrophage (RAW) 264.7 cells, and human embryonic kidney (HEK) 293 cells was 
used to validate the device.  Intercellular communication was monitored via expression 
of a fluorescent reporter by the HEK cells.  To the best of our knowledge, the present 
research is the first instance of an intercellular communication study involving three 
different patterned components (LPS, RAW cells, and HEK cells) in a microfluidic 
platform.  The model system was then used to investigate the roles of concentration of 
the initial signaling molecules, spatiotemporal dynamics, and inter-channel spacing 
affect intercellular communication.  Overall, microfluidic platforms like these will enable 
the study of complex interactions that occur between multiple cell populations. 
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4.2 Materials and methods 
Platform fabrication and design.  High resolution printing (5080 dpi) was used 
to create a mask with the design pattern on a transparency film.  The mask was used to 
pattern 50 µm high SU-8 2050 photoresist (Microchem, Newton MA) features on a 
silicon wafer by photolithography [31-33].  Poly(dimethysiloxane) (PDMS, General 
Electric RTV 650 Part A/B, Niskayuna NY) molds with embossed channels were 
fabricated using soft lithography by curing the pre-polymer on the silicon master for 2 
hours at 70 ºC [34].  Inlets and outlets for the liquids and cells were created in PDMS 
using a 23G steel punch.  The surface of the PDMS replica and a clean glass coverslip 
(Fisher Scientific, Waltham MA) were treated with air plasma for 90 seconds (Model 
PDC-001, Harrick Scientific, Pleasantville NY) and irreversibly bonded to complete the 
device assembly.  The device inlets were then connected to 1 mL syringes (BD 
Biosciences, Franklin Lakes NJ) with PTFE tubing (24G, Cole-Parmer, Vernon Hills IL).  
All the syringes were actuated by a constant pressure syringe pump (PhD 2000, 
Harvard Apparatus, Holliston MA). 
Cell culture, device setup, and ELISA.  RAW (ATCC TIB-71, Manassas VA) 
and HEK cells (ATCC CRL-1573) were cultured in DMEM medium (Sigma Aldrich, St. 
Louis MO) supplemented with 10% fetal bovine serum (Gemini Bio-Products, Woodland 
CA) and 100 U/mL penicillin/streptomycin (Gibco, Carlsbad CA).  Cells were harvested 
and resuspended at a concentration of 106 cells/mL.  The cells were encapsulated in 
Matrigel (BD Biosciences) by mixing at a volumetric ratio of 30:70.  The encapsulated 
cells were then loaded into the device and a continuous supply of medium was pumped 
into the device at a flow rate of 10 μl/hr. A TNF-α ELISA (Life Technologies, Carlsbad 
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CA) was performed by stimulating RAW cells with various LPS concentrations for 6 
hours and measuring TNF-α production. 
Genetic constructs.  HEK cells (1x104) were seeded into a 96 well plate and 
incubated with polybrene and a NFKB-GFP lentiviral vector (SABiosciences, Valencia 
CA) at a mode of inheritance of 20.  To generate stable transfected HEK NFKB cell 
lines, cells were selected by the addition of 800 μg/mL puromycin (Sigma Aldrich) 
starting 3-4 days post transduction. 
Confocal microscopy, image processing, and statistical analysis.  To 
analyze the fluorescent response of the HEK cells in a 3D matrix, images were acquired 
using a laser scanning confocal microscope (Zeiss LSM 710) with a 20x, 0.8 NA 
objective.  The fluorescent intensity of each cell was measured using ImageJ (NIH) 
Region of Interest (ROI) manager [35,36].  Analysis of the variance was performed on 
the experimental data to determine statistical significance. 
Modeling of diffusion of soluble factors.  The LPS concentration was 
calculated analytically by solving Fick’s second law of diffusion, Equation (1).  The 
transient, one-dimensional solution with pulsed boundary conditions assumes no 
adsorption and desorption.  The TNF-α concentration profile was found by numerically 
solving Equation (1) using MATLAB (MathWorks, Natick MA). 
4.3 Results and discussion 
Microfluidic platform to study intercellular communication.  We designed 
and fabricated a microfluidic platform to study intercellular communication in a 3D 
microenvironment between two cell populations (Figure 4.1).  The device enables long 
term culture (days) of two cell types in a 3D gel without disrupting the signaling gradient 
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between the cell populations.  The platform is comprised of three 300-μm wide and two 
200-μm wide parallel channels, which enable encapsulation of a sufficient number of 
cells for intercellular communication studies.  The channels were 50-μm tall and 
separated by arrays of 100 μm diameter posts with an end-to-end separation of 100 μm.  
This channel height reduces photobleaching by limiting the number of focal planes while 
still allowing cells to grow in a 3D environment.  The arrays of posts between adjacent 
channels aid in patterning of the gel: surface tension pins the interfaces between the 
posts.  The resulting gel barrier still allows for diffusion of molecules between adjacent 
channels [27].  Media is supplied to the cells from a 400-μm wide channel placed 
perpendicularly at one end of all the separation and cell channels.  The nutrients from 
the media supply channel can diffuse through the gel to the cells patterned in the 
channels without disrupting the signaling gradients between the cell populations.  The 
width of the media supply channel determines the required minimum flow rate of the 
medium to ensure adequate amounts of nutrients reaching the cells.  For the relatively 
wide channel used here (400 μm), the required flow rate is 1.0 µL/hr [37].  This constant 
supply of media is necessary to ensure cell viability and study intercellular 
communication for long durations, over the period of days. 
To validate the ability of the microfluidic platform to study intercellular 
communication, we used a model cell communication system based on the well-
characterized phenomenon of macrophage activation occurring in the innate immune 
system.  The model system, depicted in Figure 4.2, is comprised of: (i) the soluble 
factor LPS, a component of the outer membrane of Gram-negative bacteria, in the first 
channel; (ii) RAW cells in the second channel; and (iii) HEK cells in the third channel.  
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These components each were mixed with Matrigel and each was introduced into the 
blue cell channels (Figure 4.1A).  To physically separate the different cell populations, 
gel without cells is injected and polymerized in the grey separation channels (Figure 
4.1A).  Once the cells are positioned, LPS can diffuse to the second channel and initiate 
a signaling cascade by activating RAW cells via the TLR4/MD-2 complex [38,39].  
Activation of the TLR4/MD-2 complex is known to induce expression of the pro-
inflammatory cytokine TNF-α, which, in turn, activates HEK cells via TNF-α receptor 1 
(TNF-R1) [40,41].  GFP expression in HEK cells could in principle also, although less 
probable, be the result of other cytokines such as IL-1, IL-2, and LTB4 by activation of 
the transcription factor NFKB [42].  Determining exactly which cytokine is responsible for 
GFP expression is beyond the main point of the work presented here: introducing the 
application of computational modeling and microfluidic platforms to study intercellular 
communication. 
The effects of concentration and distance on intercellular communication.  
To determine how the concentration and geometry affect the spatial and temporal 
distribution of signaling molecules inside the microfluidic platform, the concentration of 
the signaling molecules in the platform was calculated by solving Fick’s second law of 
diffusion (Equation 1). 
  
  
  
   
   
      (1) 
The concentration of LPS in the middle channel (Point A, where the RAW cells reside) 
was calculated by analytically solving Equation (1).  The transient, one-dimensional 
solution with pulsed boundary conditions assumes no adsorption and desorption of 
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signaling molecules. Equation (2), describes the analytical solution for a known initial 
concentration of LPS. 
  
  
  
     
 
   
          (2) 
The concentration, C, is a function of the initial mass (M) of LPS, the cross sectional 
area of the device (A), the diffusivity (D), time (t), and the distance from the initial LPS 
position (Z).  The diffusivity of LPS and TNF-α in Matrigel were estimated to be 6.16×10-
8 and 3.22×10-7 cm2/s, respectively [43].  As the concentration of LPS directly affects the 
rate of TNF-α production by RAW cells, the concentration of LPS at Point A in Figure 
4.3A was modeled.  From this calculation, the concentration of TNF-α at various LPS 
concentrations was determined by performing a TNF-α ELISA and stimulating the RAW 
cells with LPS (shown in supplementary material, Figure 4.4).  Assuming a 1-hour delay 
from empirical evidence and a constant rate of TNF-α production, the concentration of 
TNF-α in the third channel (to the right, in Point B, where the HEK cells reside, see 
Figure 4.3A) was determined by numerically solving Equation (1).  Using these 
equations and assuming a fixed inter-channel spacing (X) of 0.7 mm between cell 
populations, the concentration of each signaling molecule at the respective point in the 
device was plotted as a function of time (Figure 4.3B).  The results of this model 
illustrates that the initial concentration of LPS added to the device significantly affects 
the resulting TNF-α concentration as expected, with the highest starting concentration of 
LPS resulting in the highest concentration of TNF-α.  However, the initial LPS 
concentration does not strongly affect the temporal aspect of intercellular 
communication as the RAW cells still produce TNF-α at low concentrations of LPS. 
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Similar to the initial LPS concentration, the inter-channel spacing between the 
cell populations also affects the intercellular communication.  Assuming a constant initial 
LPS concentration of 50 ng/mL and using Equation (2) and the numerical solution of 
Equation (1), the concentration of LPS at Point A and TNF-α at Point B for various 
values of inter-channel spacing (X) was calculated (Figure 4.3C).  Varying the inter-
channel spacing has two main effects.  First, increasing the spacing leads to increased 
diffusion time for both LPS and TNF-α.  The additional time required for LPS diffusion 
causes TNF-α production to occur later.  Second, an increase in channel spacing 
effectively decreases the concentration of signaling molecules due to an increased 
volume, as can be noted by the decrease in LPS concentration with increasing inter-
channel spacing (Figure 4.3C).  Hence, the increased spacing dilutes the signal 
strength. Still, in certain situations smaller distances between the cell channels may not 
be appropriate.  For example, increasing the inter-channel spacing modulates the 
temporal and spatial distribution of signaling molecules enabling controlled 
measurement of a specific signaling cascade. 
In addition to initial LPS concentration and inter-channel spacing, the length of 
time required for the RAW cells to begin producing TNF-α also affects the distribution of 
signaling molecules.  The TNF-α concentration in the microfluidic platform was 
calculated using delays in TNF-α production of 0, 1, and 2 hours (Figure 4.5).  An 
increase in the time required for TNF-α production causes a decrease in TNF-α 
concentration when comparing concentrations at the same time point.  While the time 
required for signaling molecule production is dependent upon the cellular system used, 
the delay in production directly affects intercellular communication.  Hence, this analysis 
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should provide insight to future users when determining appropriate timescales for study 
of intercellular communication. 
Overall, these calculations provide a guideline for the design of a microfluidic 
platform with appropriate channel geometries, as well as for experiments with initial 
concentrations of signaling molecules such that the complete spatial and temporal 
characteristics of the intercellular communication can be studied. 
Analysis of intercellular communication in microfluidic platform.  To monitor 
the intercellular communication between two cell populations within the microfluidic 
platform, the cell communication model system was combined with the microfluidic 
platform (Figure 4.1B).  RAW and HEK cells were mixed with Matrigel and added to the 
second and third cell channel, respectively.  Varying concentrations of LPS (0-50 
ng/mL) were added to the first channel to modulate the responsiveness of the HEK 
cells.  To analyze the intercellular communication inside the microfluidic platform, HEK 
cells were imaged using a confocal microscope after 14 hours of incubation.  This 14 
hour incubation period allowed for sufficient production and diffusion of all soluble 
molecules as well as expression of GFP.  The fluorescence of HEK cells also was 
measured in the absence of LPS (0 ng/mL).  In addition, a LPS concentration of 5 
ng/mL was added to a platform that did not contain any RAW cells (RAW-) to determine 
the sensitivity of the HEK cells to LPS.  As a third control, the HEK cells were added to 
the platform in the absence of both LPS and RAW cells (HEK+).  In all three control 
experiments (0 ng/mL LPS, RAW-, and HEK+), a similar low level of fluorescence is 
observed, presumably due to constitutive expression of GFP.  The HEK+ control 
experiment and Figure 4.4 (depicting the relation between LPS concentration and TNF-
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α production) indicate that the main reason for the observed GFP expression in HEK 
cells is due to TNF-α produced by the macrophage when stimulated by LPS.  The 
fluorescent response of HEK cells expectedly increased as the concentration of LPS 
increased inside the channels (Figure 4.6), with an LPS concentration of 50 ng/mL 
inducing the strongest fluorescent response from the HEK cells.  In addition, the 
fluorescent intensity of the HEK cells was significantly different in all cases (p < 0.05), 
which validates the ability to quantify intercellular communication using this microfluidic 
platform.  Further, these results correlate with the concentrations modeled earlier 
(Figure 4.3) and demonstrate how to modulate experimental parameters.  Overall, this 
information demonstrates the ability to design an appropriate device for the study of 
intercellular communication.  
We also studied the relationship between intercellular communication and time 
using the same cell communication model system in the microfluidic platform.  An LPS 
concentration of 50 ng/mL was chosen for this study (added to the platform along with 
the RAW and HEK cells), as this concentration led to maximum GFP expression (see 
above) and will enable better characterization of the temporal dynamics of the 
intercellular communication.  Intercellular communication was quantified inside the 
microfluidic platform by measuring GFP expression in the HEK cells over an 18-hour 
time period at 4 hour intervals.  As expected the fluorescent response of the HEK cells 
increased with time (Figure 4.7).  In addition, the fluorescent intensity of the HEK cells 
was significantly different between each measured time point except the 14 and 18 hour 
conditions (p < 0.05). This study shows that the methodology reported here can also be 
used to analyze spatiotemporal intercellular signaling events. 
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Overall, the results in Figure 4.6 and Figure 4.7 establish, to the best of our 
knowledge, the first experimental quantification of cue-to-cell-to-cell intercellular 
communication between multiple cell populations inside a 3D microfluidic platform.  
Further, the spatial and temporal response of the system is described when in 
combination with the simulated results from Figure 4.3. 
4.4 Conclusions 
This chapter describes the design and application of a microfluidic platform to 
study intercellular communication in a 3D microenvironment.  The platform enabled 
study of cell communication via soluble molecules in real-time and was designed to 
mimic the early stages of a bacterial infection.  We demonstrate an alternative 
arrangement for the media channel compared to previous reports that facilitates study 
of intercellular communication between multiple cell populations [15,23-28].  This 
arrangement reduces the number of media channels compared to the previously 
reported configurations.  By varying the initial LPS concentration, a significant difference 
in the fluorescent response of the HEK cells was observed.  This outcome 
demonstrates the ability to quantify intercellular communication in a defined model 
system in 3D using a microfluidic platform. 
Further, this chapter shows that analytical and computational modeling can be 
used effectively to guide the design of an appropriate platform and associated 
experimental conditions for intercellular communication studies.  Altogether, these three 
studies demonstrate the ability to study the effects of (i) concentration of the initial 
signaling molecules, (ii) spatiotemporal dynamics, and (iii) inter-channel spacing on 
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intercellular communication.  This approach, based on diffusional modeling and 
experimental use of microfluidic platforms such as the one reported in this study, will 
enable studies of cell-cell communication between multiple cell populations in a 3D 
microenvironment. 
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4.5 Figures 
 
Figure 4.1.  Schematic of microfluidic platform.  [A] Top down view of the 
microfluidic platform’s channels.  The blue channels contain cell-gel mixtures.  The grey 
channels are filled with gel and physically separate the different cell populations.  The 
red channel continuously supplies medium to the cell populations.  [B] Cross sectional 
view of the microfluidic platform.  The cell communication model system can be added 
to the device with LPS in the leftmost channel, RAW cells in the middle channel, and 
HEK cells in the rightmost channel.  [C] A photograph of the microfluidic platform. 
 
 
 
 
Figure 4.2.  Illustration of cell communication model system.  LPS diffuses through 
the microenvironment and stimulates the RAW cells.  The activated RAW cells produce 
TNF-α, which diffuses through the microenvironment to the HEK cells.  Upon activation, 
the HEK cells express GFP. 
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Figure 4.3. Concentration of signaling molecules throughout the microfluidic 
platform.  [A] Top down view of the microfluidic platform’s channels and channel 
spacing (X).  Point A and point B are the locations from where LPS and TNF-α are 
calculated, respectively.  Modeled concentrations of LPS and TNF-α as [B] initial LPS 
concentration varies with a fixed channel width of 0.7 mm and [C] channel spacing (X) 
varies with a fixed initial LPS concentration of 50 ng/mL. 
 
 
 
 
Figure 4.4. Graph depicting TNF-α concentration after six hours of stimulation 
with varying LPS concentrations.  Error bars represent the standard deviation 
calculated from all experiments; experiments were repeated six times. 
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Figure 4.5. Concentration of signaling molecules modeled throughout the 
microfluidic platform with [A] no delay, [B] a 1-hour delay, and [C] a two-hour 
delay in TNF-α production.  Solid lines denote LPS concentration calculated at Point 
A; dashed lines denote TNF-α concentrations calculated at point B.  Plots on the left 
vary the initial LPS concentration with a constant inter-channel spacing of 0.7 mm.  
Plots on the right vary inter-channel spacing with a constant initial LPS concentration of 
50 ng/mL. 
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Figure 4.6. Fluorescent expression of HEK cells.  LPS concentration was varied over 
the range of 0 – 50 ng/mL and the fluorescence intensity of the HEK cells was analyzed.  
In addition, 5 ng/mL of LPS was added to the device without the RAW cells (RAW-); 
HEK cells were added to the device without any other component (HEK+).  Error bars 
represent the standard deviation calculated from all experiments; experiments were 
repeated six times resulting in at least 90 cells analyzed for each value.  Significant 
differences are labeled by asterisks (* P < 0.05). 
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Figure 4.7. Fluorescent expression of HEK cells when incubated with RAW cells 
and an LPS concentration of 50 ng/mL.  The fluorescent intensity of the HEK cells 
was analyzed every four hours from 2 to 18 hours.  Error bars represent the standard 
deviation calculated from all experiments; experiments were repeated five times 
resulting in at least 50 cells analyzed for each value.  Significant differences are labeled 
by asterisks (* P < 0.05).  
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CHAPTER 5 
Methods to study the tumor microenvironment under 
controlled oxygen conditions 
≠ 
5.1 Hypoxia in the tumor microenvironment 
The tumor microenvironment consists of populations of transformed cells, 
stromal cells (e.g., fibroblasts, chondrocytes), vascular cells (e.g., endothelial cells, 
pericytes) and inflammatory cells (e.g., neutrophils, macrophages), along with acidity 
(lactic acid from enhanced glycolysis), increased interstitial pressure, and low oxygen 
partial pressures [1-3].  As tumors grow outward away from the local vascular 
architecture, and become increasingly metabolically active, formation of variable 
hypoxic regions throughout the solid mass is inevitable [4].  Neoplastic angiogenesis 
occurs in an attempt to restore oxygenation, but this neo-vasculature is often insufficient 
and poorly arranged.  This leads to the development of even further gradients of 
oxygen, nutrients, and waste materials [5,6].  This poses as a therapeutic challenge as 
tumor hypoxia is associated with resistance to radiotherapy and chemotherapy and is a 
negative prognostic indicator for a more aggressive phenotype [7,8].  Furthermore, 
tumor cells associated with hypoxia are thought to be more malignant and capable of 
metastasis through avoidance of apoptosis, expression of invasion genes such as 
matrix metallo-proteases and down regulation of homeostatic genes such as E-cadherin 
[9-12]. 
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Two aspects of the TME, lower pH and hypoxia, are functionally linked via 
aerobic glycolysis (Warburg effect), the production of lactate from glucose despite the 
presence of ample oxygen [13].  When compared to the complete oxidation of glucose 
to pyruvate through the citric acid cycle and electron transport chain, this metabolic 
pathway is markedly inefficient [14].  However, aerobic glycolysis likely represents an 
adaptation to the needs of hyper-proliferative and/or hypoxic cells [3].  Rapidly dividing 
cells have anabolic needs greater than ATP; glucose can be shuttled away from ATP 
production to form other macromolecular precursors such as acetyl-CoA, glycolytic 
intermediates for amino acids, and ribose for nucleotides [15].  Furthermore, other 
metabolic alterations in cancer cells, such as increased fatty acid synthesis and 
glutaminolysis, have been suggested as adaptive changes to the constraints of rapid 
growth in hypoxia.  While the molecular switches governing these responses are still 
being unraveled, tumorigenesis and metabolism are clearly intertwined as all prominent 
oncogenic alterations have been experimentally linked to changes in metabolism [16].  
Ultimately however, the bioenergetic rearrangement towards aerobic glycolysis 
emerges from a number of factors including oncogene upregulation, tumor suppressor 
loss, mtDNA mutation, and stabilization of hypoxia inducible factor 1-α (HIF-1α) in the 
hypoxic microenvironment [17]. 
Hypoxia inducible factor (HIF) is a master regulator of cellular responses to 
lowered oxygen concentrations.  HIF-1α protein levels are the most frequently used 
marker of cellular hypoxia.  As a DNA-binding transcription factor, HIF induces more 
than 100 genes, including those coordinating metabolism (especially glycolysis), cell 
signaling, erythropoiesis, angiogenesis, cell proliferation, and apoptosis [18].  Functional 
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HIF is a heterodimer composed of an α and β subunit. HIF-α contains two oxygen-
dependent degradation domains that are hydroxylated via prolyl hydroxylase domain-
containing enzymes and subsequently degraded [19,20].  HIF-1α levels rise in hypoxia 
beginning around 5% and peak at 1% oxygen by volume [21].  HIF-1α stabilization is of 
particular importance in carcinogenesis, where activity is induced or increased by 
numerous growth-promoting signals, tumor suppressor loss, oncogene signaling and 
onco-metabolite stabilization [22,23].  Not unsurprisingly, tumors exhibiting higher levels 
of HIF-1α have correlated strongly to poorer survival times in many cancers including 
those of breast, head/neck, esophagus, stomach, and lung [7]. 
HIF-mediated effects are especially apparent in angiogenesis, in which the 
transcription factor regulates downstream events such as vascular permeability, 
extracellular matrix remodeling, endothelial cell migration/proliferation, tube formation, 
and pericyte interactions [22].  Angiogenesis is of such importance to neoplastic 
pathogenesis that much of the last half century’s cancer research efforts were focused 
on angiogenesis’ role in oxygen availability: understanding molecular underpinnings, 
revealing roles in tumor mass progression, and ultimately inhibition via receptor 
antagonism.  However, these efforts have not directly led to clinical progress as strongly 
as predicted.  In general, treatment failures seen with angiogenic inhibitors have been 
attributed to cell population selection towards those that can circumvent the specific 
angiogenic target (e.g., up/down regulation of angiogenic mediators, reliance on 
separate factors) and through a pre-existing immunity to the specific therapy (e.g., 
redundancy in signaling, pre-existing protection from stromal cells/inflammatory cells) 
[24]. 
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5.2 Challenges studying cell behavior under hypoxia 
Due to a variety of factors, including the transport of oxygen via diffusion, oxygen 
concentration gradients often exist within tissues [25].  When the transport of oxygen is 
unable to meet demand, hypoxia (sub-physiologic tissue oxygenation) occurs [26].  The 
partial pressure of oxygen in one such location where hypoxia is often found, the tumor 
microenvironment, ranges from 2 mm Hg (0.3% O2) to 15 mm Hg (2.1% O2) depending 
on tumor type (Table 5.1) [27,28].  Comparatively, arterial blood has a partial pressure 
of oxygen of 100 mm Hg (13.1% O2), and the partial pressure introduced into traditional 
cell culture is 152 mm Hg (20% O2) [29].  Thus, to support the transition between in vitro 
knowledge and clinical successes, and to more accurately mimic oxygen conditions 
seen in vivo, advanced platforms of study are needed to more closely recapitulate 
hypoxia in the TME and tissue in general (Figure 5.1). 
Table 5.1. Partial oxygen pressure (pO2) of solid tumors and the associated 
surrounding healthy tissue.  All pO2 values are combined medians of individual values 
that were measured in mmHg using an oxygen electrode (modified from [28]). 
Tumor type Median diseased pO2 Median Health pO2 
Glioblastoma 4.9 - 5.6 - 
Head and neck carcinoma 12 - 15 40 - 51 
Lung cancer 7.5 38 
Breast cancer 10 - 
Pancreatic cancer 2.7 52 
Cervical cancer 3.0 - 5.0 51 
Prostate cancer 2.7 52 
Soft-tissue sarcoma 6.2 - 18 - 
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Controlling oxygen conditions in a laboratory setting is challenging due to 
sample/reagent handling and constant diffusion of oxygen from ambient air (≈ 21%).  
For example, each step during an experiment must be performed under identical 
oxygen conditions to prevent bias and to ensure reproducibility.  A standard laboratory 
practice such as changing media for cells requires the cell culture flask to be removed 
from a gas-controlled incubator and placed in a chamber with the same desired oxygen 
concentration.  Further, fresh media must be pre-equilibrated to the same oxygen 
concentration.  The dissolved oxygen concentration in the reagent, in this case media, 
should also be measured prior to addition.  Hence, executing a series of relatively 
simple laboratory techniques quickly becomes arduous under controlled oxygen 
concentrations. 
5.3 Conventional methods to control oxygen concentration 
To control the gaseous environment for cell studies, a number of conventional 
methods are used.  The two most common methods (Figure 5.2), enable in vitro cell 
assays under hypoxia by (i) having a chamber with an air-tight seal and introducing 
specific gas concentrations, or by (ii) biochemically inducing a state of pseudo-hypoxia 
within the cell.  These two methods provide unique benefits as well as limitations for cell 
assays under hypoxia. 
Perhaps the most prevalent method to control the oxygen concentration is 
modulation of the gas mixtures entering an incubator (Figure 5.2A).  In this method, 
cells are grown and conditioned in an incubator with the desired oxygen concentration 
[30].  However, long oxygen equilibration periods and the burdensome measures taken 
to sustain hypoxia throughout all aspects of experimentation limit the effectiveness of 
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this method.  Further, gas-controlled incubators require an additional system for manual 
handling of reagents such as a glove box.  Similar tools such as hypoxia chambers 
have equivalent limitations when requiring real-time imaging or reagent manipulation 
[31].  To enable live imaging, perfusion chambers have been used in conjunction with 
microscopy to enable analysis of real-time data [32].  These perfusion chambers work 
by limiting diffusion of ambient air into the cell channel.  The oxygen conditions are 
modulated by introducing liquids with a pre-equilibrated dissolved oxygen concentration 
into the chamber.  However, handling and use of the reagents after equilibration of 
oxygen concentration is imprecise and challenging due to diffusion of oxygen from 
ambient air.  Further, current studies using this system have required cells to adhere to 
a microscope slide and, thus, the cells were not grown in a three-dimensional (3D) 
environment. While providing cells a 3D environment may be possible when using 
perfusion chambers, current studies have relied on 2D cultures.  As such, this limitation 
may affect cell behavior as 3D cell cultures are more physiologically relevant and have 
been found to differ significantly from 2D cultures in proliferation, migration, and 
expression of cell-surface receptors [33-35]. 
A second approach used to study cellular responses to hypoxia is by 
biochemically inducing a pseudo-hypoxic state in cells (Figure 5.2B).  This method is 
distinct from others as the aqueous solution remains oxygenated while investigators rely 
upon chemical treatments to induce signaling events associated with hypoxia.  A 
number of chemicals such as prolyl hydroxylase inhibitors, nickel chloride, and, the 
most widely used chemical inducer of hypoxia, cobalt chloride, stabilize the transcription 
factor HIF-1α and thus mimic hypoxia [30,36-40].  The two proposed mechanisms by 
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which cobalt chloride stabilizes HIF-1α include inactivating prolyl hydroxylases by 
chelating their iron core and replacing it with cobalt [41], or by taking up the VHL-binding 
domain of HIF-α, thus rescuing it from degradation [42].  In either case, this state of 
pseudo-hypoxia has proven to be useful for many biochemical analyses as oxygen can 
be present in samples without affecting the experiment.  However, this biochemical 
induction narrows the scope of the hypoxic study to those events downstream of the 
single HIF family of transcription factors. While HIF’s are master regulators of many 
hypoxic cell responses, cobalt chloride fails to adequately reproduce mitochondrial ROS 
signaling, rather generation of ROS from cobalt chloride physiologically differs from that 
of hypoxic ROS generation [43,44].  Furthermore, cobalt itself is cytotoxic [45], and 
cobalt chloride affects cell division and morphology [46], while in some cases inducing 
mitochondrial DNA damage and apoptosis [47,48]. Overall, these conventional methods 
are limited in their ability to support the study of cell behavior under controlled oxygen 
conditions. 
5.4 Microfluidic platforms for hypoxic studies 
Microfluidic platforms enable precise control over the local microenvironment.  
This inherent characteristic allows spatial and temporal regulation of specific chemical 
and gaseous conditions.  For example, microfluidic platforms capable of creating 
chemical concentration gradients have been used for cell migration studies [49,50].  
Further, spatiotemporal control over signaling molecules has enabled studies on cell-
cell communication between multiple cell populations [51,52].  In addition to control over 
the microenvironment, a key aspect of microfluidic platforms is that equilibration times 
are significantly reduced compared to conventional methods due to differences in scale 
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(micro vs. macro) [31,53].  To control the oxygen concentration inside microfluidic 
platforms, several different mechanisms have been employed.  The three most common 
methods (Figure 5.3) are (i) introducing oxygen scavenging chemicals into the platform 
[54,55], (ii) controlling oxygen supply by implementing adjacent gas supply channels, 
e.g., in multilayer platforms [53,56-63], and (iii) reducing oxygen supply by use of 
oxygen impermeable materials such as cyclic olefin copolymer (COC), polystyrene 
(PS), or poly(methyl methacrylate) (PMMA) [64-68].  A few other microfluidic 
approaches to control oxygen tension have been reported [66,69-71], but they are 
challenging to fabricate or more cumbersome in operation.  The remainder of this 
review focuses mostly on the three aforementioned microfluidic methods of controlling 
oxygen concentration. 
Oxygen scavenging chemicals.  One method to control oxygen concentration 
in the microfluidic platform utilizes oxygen scavenging chemicals (Figure 5.3A).  On a 
macroscale, oxygen scavenging chemicals have been used to control oxygen 
concentration in solutions [72].  However, temporal and spatial heterogeneity exist due 
to long diffusion times and a lack of control over mixing of the chemical solutions 
(convective mixing).  In microfluidic platforms, mixing occurs only via diffusion due to 
fluid flow being in the laminar flow regime.  Hence, the concentration and reaction rate 
of oxygen scavenging chemicals can be controlled well.  Oxygen concentration 
gradients have been created by generating oxygen scavenging and oxygen generating 
reactions on either side of a cell channel [54].  Similarly, modulating channel dimensions 
and sodium sulfite flow rates enabled control over the oxygen concentration in a cell 
channel [55].  Utilizing the developed platforms, the anti-cancer drug Tirapazamine was 
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tested under various oxygen concentrations on ardenocarcinomic human alveolar basal 
epithelial (A549) cells demonstrating the utility of these platforms for therapeutic testing 
[54,55].  In addition, by introducing oxygen scavenging chemicals rather than gas 
streams, ancillaries such as gas cylinders and flow controllers are not required.  
However, the continuous flow associated with this method requires syringe pumps or 
passive pumping techniques such as gravity-driven flow and surface-tension driven flow 
to introduce the oxygen scavenging (or generating) chemicals into the platform. 
Gas supply channels.  The second method to control oxygen concentration is 
based on implementing gas supply channels adjacent to cell chambers (Figure 5.3B).  
An advantage of microfluidic platforms is their ability to be designed and rapidly 
fabricated to meet desired specifications.  Hence, development of platforms with optimal 
positioning of gas channels enables control over oxygen concentration.  The most 
common geometric arrangement of gas supply channels utilizes multilayer platforms, 
with the gas channel flowing over or under a monolayer of cells [53,59-62].  These 
platforms have been used to study intracellular calcium dynamics in neonatal rat 
cardiomyocytes under hypoxia [53].  Aqueous solutions with pre-equilibrated oxygen 
concentration have been introduced offering the additional advantage of reducing 
changes in solute concentration [58].  However, this method of pre-equilibrating 
aqueous solutions is imprecise and challenging due to diffusion of oxygen from ambient 
air during handling.  In addition, these multilayer platforms can be more difficult to 
fabricate and use than single-layer platforms.  For example, care must be taken that 
features in control layers do not obstruct imaging of cells. 
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Modifications to standard laboratory tools such as the Boyden chamber [73] and 
well plates [74] have been developed to control oxygen tension.  These structures, 
commonly composed of poly(dimethylsiloxane) (PDMS) and created via replica molding, 
provide gas channels above the cell culture chamber.  Similar to a well plate, cell 
chambers open to the atmosphere have been developed to control oxygen by flowing 
gas or oxygen scavenging chemicals underneath the cells [56,63].  This open well 
platform has been used to study intracellular reactive oxygen species (ROS) levels in 
Madin-Darby Canine Kidney (MDCK) cells under oxygen gradients [56].  These 
platforms enable easy addition of chemicals and are similar to a conventional tissue 
culture dish, the platforms require cells to adhere to PDMS in a monolayer to have a 
uniform oxygen concentration for all cells.  To overcome the limitation of cells cultured 
on PDMS in 2D, a microfluidic platform capable of culturing cells in a 3D 
microenvironment while controlling the oxygen concentration was developed by 
positioning gas channels both above and below the cell chamber [57].  Overall, 
introducing gas supply channels adjacent to cell chambers has proven to be an effective 
method to control oxygen concentration.  However, further advances in user operability 
are necessary for this method to gain widespread use. 
Oxygen impermeable materials.  A third method to control oxygen 
concentration is by fabricating platforms out of oxygen impermeable materials (Figure 
5.3C).  Traditionally, microfluidic platforms have been fabricated using PDMS.  One of 
the main benefits of using PDMS is ease and speed of replica molding, allowing for 
rapid iteration in design improvements.  During cell culture, PDMS enables diffusion of 
oxygen from the atmosphere into cell channels.  However when desiring hypoxic 
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conditions, this oxygen permeability limits the ability to control oxygen tension.  To 
combat this issue, materials with low oxygen permeability (Table 5.2) can be selected 
and used to fabricate platforms.  Oxygen diffusivity is orders of magnitude higher in 
PDMS than the other materials listed.  Hence, microfluidic platforms comprised of 
alternative materials have the potential to control oxygen concentration more effectively 
by reducing diffusion from the atmosphere.  For example, platforms comprised of 
PMMA prevented oxygen diffusion from the atmosphere [64,68].  Gas permeable 
membranes embedded within the platform enable oxygen diffusion between cells and 
gas channels. With this control over oxygen concentration, growth patterns of the 
bacterium Pseudomonas aeruginosa under varying oxygen concentrations was studied, 
demonstrating the capability to study microaerobic and anaerobic conditions [68].  
Similarly, a hybrid platform consisting of PDMS and a polycarbonate (PC) film has been 
developed [65].  The relatively gas impermeable PC film, patterned above the cell 
channels, reduces diffusion of oxygen from the atmosphere above the device.  
Meanwhile, the PDMS enables oxygen diffusion from the gas channels to the cell 
chamber while physically separating the two.  Using this platform, migration studies of 
MDA-MB-231 human breast cancer cells in 3D under hypoxia were performed [65].  To 
study oxygen uptake rate in hepatocytes and endothelial cells, an oxygen impermeable 
platform consisting solely of COC has been designed [67].  Due to the nature of the 
study, this platform did not require gas to be introduced into the system and, thus, did 
not require an oxygen permeable material.  While constructing microfluidic platforms out 
of gas impermeable materials is promising, these materials are time consuming to 
pattern and can be difficult to bond and at times challenging to connect to ancillaries. 
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Table 5.2. Oxygen diffusivity in materials commonly used for fabrication of microfluidic 
platforms. 
Material 
Oxygen Diffusivity 
(10-11 m2/s) 
Refs 
Poly(dimethylsiloxane) (PDMS)    400 
 
[96] 
Polycarbonate (PC)  2.0  [97] 
Polystyrene (PS)  4.0  [97] 
Cyclic olefin copolymer (COC)  0.46  [67,98] 
Poly(methy methacrylate) (PMMA)  0.25  [99] 
Polypropylene (PP)  3.0  [100] 
 
Microfluidic platforms (Table 5.3) enable real-time studies of cell behavior such 
as cell migration, ROS generation, and therapeutic sensitivity under controlled oxygen 
conditions.  In addition, these platforms, reduce equilibration time, increase control of 
oxygen concentration, enable generation of oxygen gradients, and improve real-time 
measurements of cell behavior when compared to conventional methods [31].  Still, 
further work with microfluidic platforms is desired to increase their utility and ease of use 
in precise control of the oxygen concentration. 
5.5 Future outlook of microfluidics to control oxygen concentration 
Many questions regarding cell behavior in the TME under controlled oxygen 
conditions remain.  Further development of the tools used to control these conditions is 
needed to enable accurate analysis of cell behavior.  Specifically, with respect to 
microfluidic platforms a number of technical and pragmatic issues still exist.  These 
challenges must be overcome to enable studies leading to a deeper understanding of 
the TME.  
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Table 5.3. Summary of reported microfluidic platforms that enable control of oxygen 
concentration in cell studies. 
Material used Cells in 3D? Device features Refs. 
Introducing oxygen scavenging chemicals for oxygen control 
PDMS No Chemical reactions generate oxygen gradients [54] 
PDMS No 
Top of platform open to atmosphere and oxygen 
scavenging chemicals below cell chamber 
[63] 
PDMS No Oxygen scavenging chemicals in cell chamber [55] 
Gas supply channels placed adjacent to cell chambers for oxygen control 
PDMS No Gas channel above or below cell chamber 
[53,59,
61,62] 
PDMS No Top of platform open to the atmosphere [56] 
PDMS No Valves actuated by Braille bin to circulate media [69] 
PDMS No Boyden chamber insert coated with Parylene-C [73] 
PDMS Yes Gas channels above and below cell chamber [57] 
PDMS No Insert for well plates [74] 
PDMS No Oxygen controlled with pre-equilibrated water [58] 
Platforms fabricated out of oxygen impermeable materials for oxygen control 
PMMA No PMMA exterior with gas permeable membrane [64] 
PC, PDMS Yes PC film patterned above PDMS channels [65] 
COC, PS No Patterned channels in COC and PS [66] 
COC, PMP Yes Completely composed of COC or PMP [67] 
PMMA No PDMS channels with PMMA exterior [68] 
 
An issue that is beginning to plague microfluidic platforms is ease of use, 
especially pertaining to the requirement of external devices [75,76].  Toward this end, 
new techniques, procedures, and platforms have been developed to provide 
researchers who are not familiar with microfluidics the option to use these valuable 
tools.  For example, surface tension based passive pumping enables addition of fluids 
and is compatible with micropipettes [77].  A technology that is already available, ‘Kit-
On-A-Lid-Assay’, provides self-contained microfluidic cell-based assays, integrating all 
steps required to perform the assay [78].  Increased understanding of capillary flow in 
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suspended microfluidic platforms offers increased accessibility, functionality, and 
simplicity of fabrication [79].  Still, the need for gas cylinders and mass flow controllers 
to introduce gas streams into microfluidic platforms still complicates experiment setup 
and execution.  Hence, new and innovative designs and ideas are required to reduce 
the complexity of microfluidic platforms for oxygen dependent cell studies. 
To move beyond validation of platform studies, scientists must be able to 
seamlessly integrate these microfluidic platforms into their laboratory toolkit.  However, 
this integration requires familiarity and confidence with the particular microfluidic 
platform.  Implementation of microfluidic platforms in current biology and biochemistry 
laboratory courses would provide the needed exposure to microfluidics for a broad 
range of potential users, which would lessen the barrier towards integrating this 
technology into many biological studies. 
Technical issues, such as accurately recapitulating the TME on a microfluidic 
platform, also must be addressed.  The TME directly affects tumor progression and 
therapeutic resistance, making accurate modeling critical [1,80].  At present, microfluidic 
platforms have been developed and applied to study interactions between the different 
cellular components of the TME [75].  However, to date these platforms have been used 
primarily to study proof-of-concept biology.  To accurately model the TME, further 
development of imaging techniques that depict a tumor’s cytotype are needed.  The 
tumor cytotype, defined as the identity, quantity, and location of each of the different cell 
types that make up a tumor, influences how a tumor will evolve over time.  Current 
imaging techniques such as optical coherence tomography (OCT) [81], positron 
emission tomography (PET) [82,83], magnetic resonance imaging (MRI) [82], as well as 
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light sheet fluorescence microscopy (LSFM) [84] enable non-invasive imaging of the 
TME and associated characteristics such as hypoxia and pH.  However, these 
techniques are limited by their chemistry, resolution, or inability to provide quantitative 
results and typically cannot fully depict the TME.  Hence, more detailed analyses and 
improved imaging of the tumor cytotype is needed for engineers and scientists to more 
closely mimic these complex tissues, for example within a microfluidic platform. 
Another challenge associated with studying cell behavior under controlled 
oxygen concentrations in microfluidic platforms is the need to develop and integrate 
methods for endpoint measurements.  Traditional endpoint measurements in cell 
studies performed with microfluidic platforms rely on image analysis for phenotypic 
behavior such as cell migration or proliferation.  To provide more thorough analysis of 
cell behavior and function under hypoxia, further integration with current biochemical 
tools is necessary.  For example, integrating a microfluidic platform with genetically 
encoded GFP-based redox sensors could enable measurement of the oxidative state of 
a cell under hypoxia [32,85,86].  Development of methods to quantify secreted 
molecules would provide insight into cell signaling under hypoxia, however, more 
research is necessary for current techniques to be adapted under controlled oxygen 
concentrations [87,88].  To measure levels of protein, RNA, or DNA, platforms enabling 
cell lysis for qRT-PCR and western blots off-chip have been developed and qRT-PCR 
completely on chip has even been performed [89,90].  Still, challenges with these 
techniques such as harvesting individual or small groups of cells cultured in complex 3D 
environments remain. 
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Beyond cancer and the TME, the stem cell microenvironment [91] as well as 
diseases such as Alzheimer’s [92], rheumatoid arthritis [93], chronic kidney diseases 
[94], and non-alcoholic fatty liver disease [95] have all been associated with hypoxia.  
While the context of this article is specific to the TME, one should note that these tools 
could also be applied to these other hypoxia related microenvironments. 
5.6 Concluding remarks 
Hypoxia affects a number of cellular behaviors in the TME, however, studying 
these processes in a controlled manner has proven to be challenging.  In general, 
conventional methods enable macroscale studies, but are limited with respect to real-
time imaging.  More recently, microfluidic platforms have been developed to study cell 
behavior under controlled oxygen concentrations.  Although these platforms have been 
used primarily in validation studies, compatibility with microscopy provides an 
opportunity to further study cancer cell biology under hypoxia. However, further 
technical development of these tools is required for sophisticated biological 
experiments.  Specifically, methods to increase ease of use will provide more facile 
addition and manipulation of reagents, while more accurate modeling of the TME is 
necessary to interpret the experimental results and thereby better understand tumor 
progression and therapeutic efficacy in a relevant system.  In addition, to increase 
adoption of microfluidic platforms, increased training opportunities are necessary, for 
example through implementation of experiments involving simple microfluidic tools in 
existing laboratory courses in molecular and cell biology programs. 
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5.7 Figures 
 
Figure 5.1. Illustration of the tumor microenvironment (TME) with distinct cell 
types and hypoxic regions.  Hypoxia induces glycolysis, therapeutic resistance, and 
upregulation of HIF-1α.  Microfluidic platforms enable real-time studies of cell behavior 
under hypoxic conditions, or under oxygen concentration gradients. 
 
 
 
Figure 5.2. Illustrations of three conventional methods that enable control of 
oxygen concentration during cell studies.  [A] a gas-controlled incubator, [B] a glove 
box, and [C] biochemical induction of a pseudo-hypoxic state.  
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Figure 5.3. Microfluidic platforms that enable control over oxygen concentration, 
shown in top down view (left) and cross sectional view (right). Dashed line indicates 
where the cross-section was made. The different platforms can control oxygen 
concentration by [A] introducing oxygen scavenging chemicals, [B] altering the 
diffusional distance of oxygen, or [C] incorporating relatively oxygen impermeable 
materials.  
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CHAPTER 6 
Open-welled microfluidic platform for cell studies 
under hypoxia 
6.1 Introduction 
In solid tumors, poorly arranged and malfunctioning vasculature can cause 
regions of low oxygen conditions to occur.  These regions of hypoxia (physiologically 
low levels of oxygen) present a unique set of challenges towards the treatment of solid 
tumors.  Clinically, tumor hypoxia is a negative prognostic indicator for a more 
aggressive phenotype and has been associated with therapeutic resistance [1,2].  In 
addition, hypoxia related changes of the proteome and genome have been linked to 
disease progression in a variety of human malignant tumor types [3-5].  One such 
hypoxia related change is the stabilization of hypoxia inducible factor-alpha (HIF-α).  In 
the presence of physiologic oxygen levels, HIF-α is marked for ubiquitination via 
oxygen-sensitive prolyl hydroxylases and subsequently degraded [6,7].  However, when 
stabilized, the transcription factor HIF can induce more than 100 genes, including those 
regulating metabolism, cell signaling, erythropoiesis, angiogenesis, cell proliferation and 
apoptosis [8].  Beyond stabilization, HIF activity is induced or increased by many 
growth-promoting signals, tumor suppressor loss, oncogene signaling, and onco-
metabolite stabilization [9,10].  Even with this knowledge, the complex interactions 
between hypoxia and cancer cell behavior are still being unraveled.  Thus, methods 
enabling control over oxygen conditions during cell studies are essential to understand 
the behavior of cancer cells under hypoxia. 
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Microfluidic platforms have recently been developed to control oxygen 
concentration in the cellular microenvironment [11].  For example, platforms fabricated 
out of gas impermeable materials have demonstrated control oxygen concentration [12-
16].  Further, devices with cell chambers located adjacent to gas channels have been 
developed and validated [17-22].  In general, these platforms reduce equilibration times 
and enable real-time imaging of cellular events compared to conventional methods such 
as the gas controlled incubator [17,23].  However, a limitation with many of the 
developed platforms is their difficulty of use.  Towards this end, microfluidic platforms 
with chambers open to the atmosphere have been developed [24,25].  These devices 
enable easy manipulation of cells, media, and reagents by micropipette while controlling 
oxygen conditions.  However, further characterization of parameters affecting the 
oxygen concentration such as membrane thickness and media height in such platforms 
is necessary going forward. 
In this chapter, we present the design, validation, and use of an open-welled 
microfluidic platform for three-dimensional cell studies that enables control of oxygen 
concentration down to 0.6%.  The open-welled device is easy to use as cells and 
reagents can be added and manipulated by a micropipette.  To fully characterize the 
platform, the affect of parameters such as gas composition, addition of a gas 
impermeable barrier, membrane thickness, and media height on oxygen concentration 
within the platform were experimentally and computationally determined.  With the 
platform fully characterized, Chinese Hamster Ovary (CHO) cells were introduced and 
grown in the platform.  HIF-α activity levels at varying oxygen concentrations were 
monitored via expression of a fluorescent reporter by the CHO cells.  The HIF-α activity 
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levels in CHO cells were found to increase starting at 6.2% O2, reaching a maximum 
near 0.6% O2.  The results from this study demonstrate the ability to study cell behavior 
under controlled oxygen conditions in this microfluidic platform. 
6.2 Materials and methods 
Platform design and fabrication.  The microfluidic platform is comprised of two 
layers, a cell chamber layer and a thin gas channel layer.  To create the gas channel 
layer, high resolution printing (5080 dpi) was used to create a mask with the design 
pattern on a transparency film.  The mask was used to pattern 20 µm high features out 
of SU-8 2025 photoresist (Microchem, Newton MA) on a silicon wafer by 
photolithography [26-28].  Poly(dimethysiloxane) (PDMS, General Electric RTV 650 Part 
A/B, Niskayuna NY) was patterned on the silicon wafer by spin-coating and curing the 
pre-polymer for 30 minutes at 70 ºC [29].  The cell chamber was created by punching a 
4-mm wide hole in a cured PDMS slab.  The PDMS slab was then irreversibly bonded to 
the gas layer by treatment with air plasma for 90 seconds (Model PDC-001, Harrick 
Scientific, Pleasantville NY).  Inlets and outlets for the gas stream were created in 
PDMS using a 23G steel punch. The surface of the PDMS replica and a clean glass 
coverslip (Fisher Scientific, Waltham MA) were treated with air plasma for 90 seconds 
and irreversibly bonded to complete the device assembly.  The device inlets were then 
connected to a gas cylinder (SJ Smith, Urbana, IL) with PTFE tubing (24G, Cole-
Parmer, Vernon Hills IL) and the gas flow rate was controlled via a mass flow controller 
(Sierra Instruments SmartTrak 2, Monterey CA). 
Measuring PDMS membrane thickness.  The PDMS membrane thickness was 
controlled by spincoating PDMS at calibrated rotational speeds.  To measure the 
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membrane thickness, images of the membranes were acquired using an optical 
microscope (Leica Z16 APO) equipped with a digital camera (Leica DFC280).  The 
thickness of the membrane was then measured by analyzing the images using ImageJ 
(NIH). 
Cell culture, genetic construct, and transduction.  CHO cells (ATCC CCL-61, 
Manassas VA) were cultured in DMEM (Sigma Aldrich, St. Louis MO) supplemented 
with 10% fetal bovine serum (Gemini Bio-Products, Woodland CA) and 100 U/mL 
penicillin/streptomycin (Gibco, Carlsbad CA).  To produce lentiviral particles, the 6U-
HBR plasmid (Addgene plasmid 42621, Cambridge MA) was transfected into HEK293T 
cells (Invitrogen, Carlsbad CA) by lipofectamine transfection (Life technologies, 
Carlsbad CA) [30].  The media was changed 24 hours after transfection and the viral 
supernatants were collected and filtered after 72 hours.  The viral supernatants were 
centrifuged at 6000 rpm for 45 minutes at 4°C.  The concentrated viral particles were 
then added into the CHO cell media, creating a stably transfected cell line.  After 
creation of the stable cell line, cells were harvested and resuspended at a concentration 
of 106 cells/mL. The cells were encapsulated in Matrigel (BD Biosciences) by mixing at 
a volumetric ratio of 30:70. The encapsulated cells were then loaded into the device 
with a micropipette. 
Measurement of oxygen concentration.  To experimentally measure oxygen 
concentration within the microfluidic platform, the fluorescent dye, ruthenium tris(2,2’-
dipyridyl) dichloride hexahydrate (RTDP) was introduced into the cell chamber of the 
platform [31,32].  The fluorescence of RTDP is quenched in the presence of oxygen.  
Thus, by starting at atmospheric conditions (21% O2) and then introducing gas into the 
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platform, the change in fluorescent intensity can be related to oxygen concentration 
using the Stern-Volmer equation (Equation 1). 
  
 
              (1) 
The uninhibited dye intensity, I0, was found by introducing sodium sulfite, an oxygen 
scavenging chemical, to create anoxic (0% O2) conditions and calibrate the readings.  
The quenching constant, Kq, was calibrated using the fluorescent intensity at 
atmospheric and anoxic condtions.  The images were acquired using an inverted 
fluorescent microscope (Lecia DMI 400b) with a 20x, 0.4 NA objective.  The fluorescent 
intensity was measured using ImageJ ROI manager [33,34]. 
Computational modeling of oxygen concentration.  A computational model of 
the microfluidic platform was constructed using the finite element analysis software 
Comsol (Comsol, Burlington MA).  Transient and steady-state numerical simulations 
were performed by solving the convection-diffusion equation.  The simulations enabled 
investigation and computation of the oxygen concentration in the device upon varying 
parameters such as PDMS membrane thickness, media height, and gas stream 
composition. 
Confocal microscopy, image processing, and statistical analysis.  To 
analyze the fluorescent response of the CHO cells in a 3D matrix, images were 
acquired using a laser scanning confocal microscope (Zeiss LSM 710) with a 20x, 0.8 
NA objective. The fluorescent intensity of each cell was measured using ImageJ ROI 
manager.[33,34] Analysis of variance was performed on the experimental data to 
determine statistical significance. 
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6.3 Results and discussion 
Design of open-welled microfluidic platform to control oxygen conditions.  
We designed and fabricated a microfluidic platform that enables cell behavior studies 
under controlled oxygen conditions.  The goal of the designed device is to enable 
manipulation of cells, reagents, and media with a micropipette while controlling oxygen 
conditions.  The platform is comprised of two PDMS layers, a gas layer and a cell layer 
(Figure 6.1).  The cell layer, residing on top of the gas layer, enables cells encapsulated 
in a 3D gel to be added into a 4-mm wide cell chamber via micropipette.  After addition 
of the cells, media can be added to the cell chamber to provide nutrients.  The gas layer 
runs at the base of the platform and is comprised of 50 parallel channels.  Each channel 
is 20-µm tall, 50-µm wide, and patterned 50-µm apart.  Gas streams flow through the 
channels, enabling control over oxygen concentration by gas diffusing through the 
PDMS membrane to the cell chamber. 
Validation of oxygen concentration within the microfluidic platform.  To 
determine the oxygen concentration within the microfluidic platform, we computationally 
modeled and experimentally measured the oxygen concentration in the cell chamber.  
In both the experimental measurements and computational simulations, a PDMS 
membrane thickness of 20 µm and a media height of 1.5 mm were used.  The oxygen 
concentration within the microfluidic platform was computationally simulated by 
developing a model of the device in the finite element analysis software, Comsol 
(Figure 6.2).  The transient simulation determined the oxygen concentration at different 
time points after introducing a gas stream with a composition of 0% oxygen into the 
microfluidic platform.  The simulated oxygen concentration equilibrated within 5 minutes 
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of the gas stream introduction.  This model was further employed to investigate the 
affects of media height, membrane thickness, and the addition of an impermeable 
barrier on oxygen concentration. 
The oxygen concentration within the microfluidic platform was experimentally 
measured by analyzing the change in fluorescence of RTDP.  The oxygen concentration 
within the platform was measured as gas streams with compositions of 0%, 1%, and 5% 
O2 were introduced (Figure 6.3).  Expectedly, the oxygen concentration within the 
platform equilibrated near the level of oxygen in the gas stream.  Further, the oxygen 
concentration equilibrated within 10 minutes of gas being introduced.  Overall, the 
computational simulations predict an oxygen concentration similar to the experimentally 
measured values, demonstrating agreement between our computational and 
experimental results. 
The effects of an oxygen impermeable barrier on oxygen concentration.  
The open-well design of the microfluidic platform enables easy manipulation of cells and 
reagents.  However, this feature also allows oxygen from the atmospheric air to diffuse 
to the cell chamber.  This diffusion of oxygen decreases control over the oxygen 
conditions.  One method to increase control over the oxygen conditions is to simply 
place an oxygen impermeable barrier on top of the open-welled cell chamber.  To 
determine the affect of placing this barrier on the microfluidic platform, the equilibrated 
oxygen concentration was both simulated and experimentally measured with the 
designed open-well configuration and also with the top covered by a glass coverslip 
acting as an oxygen impermeable barrier (Figure 6.4).  The equilibrated oxygen 
concentration within the microfluidic platform was reduced from approximately 1.3% O2 
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in the open-welled condition to approximately 0.6% O2 with the impermeable barrier.  
Thus, placing an oxygen impermeable barrier on top of the microfluidic platform enables 
more precise control over the oxygen concentration.  Further, by placing but not 
bonding the barrier to the platform, the platform retains all of the desired functionality 
while increasing control over the oxygen conditions. 
The effects of media height and membrane thickness on oxygen 
concentration.  In the designed microfluidic platform, gas diffuses from the gas channel 
through the PDMS membrane to the cell chamber.  Diffusion of oxygen via this route 
enables control over the oxygen concentration within the microfluidic platform.  Thus, 
modulating the PDMS membrane thickness will affect the oxygen concentration within 
the device.  To determine the effect of PDMS membrane thickness on oxygen 
concentration, the equilibrated oxygen concentration was both computationally 
simulated and experimentally measured (Figure 6.5A).  The membrane thickness was 
varied from 20-150 µm resulting in a change in oxygen concentration from 
approximately 1.3% O2 to 4.7% O2.  Expectedly, as membrane thickness increases the 
oxygen concentration within the platform increases.  Thus, to reduce oxygen 
concentration, the membrane thickness should be as small as possible. 
Another parameter associated with the microfluidic platform affecting oxygen 
concentration is media height.  Oxygen from the atmospheric air diffuses through the 
media to the cells located at the bottom of the cell chamber.  Thus, the relationship 
between media height and oxygen concentration within the platform was explored.  The 
media height was varied from 0.5-1.5 mm and the oxygen concentration within the 
microfluidic platform was experimentally measured and computationally simulated 
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(Figure 6.5B).  The oxygen concentration decreased as the media height increased.  
This occurred because increasing the media height increases the distance oxygen from 
the atmospheric air must diffuse.  In addition, one should note that the media height will 
change over long time periods due to evaporation and, thus, may affect the oxygen 
concentration.  Overall, both media height and membrane thickness affect oxygen 
concentration within the microfluidic platform.  
Measuring HIF stabilization at various oxygen concentrations.  Sub 
physiologic oxygen levels are well known to fundamentally regulate many aspects of 
cell biology.  Most of the effects of hypoxia involve the transcription factor HIF.  Thus, 
measuring HIF activity levels at various oxygen concentrations will help to better 
understand the link between hypoxia and cell behavior.  To measure HIF activity levels, 
a genetically encoded eYFP reporter was employed.  This reporter has previously been 
demonstrated to correlate with HIF protein levels [30].  CHO cells with the genetically 
engineered reporter were introduced into the microfluidic platform and exposed to 
oxygen concentrations ranging from 0.6% O2 to 21% O2 for 14 hours.  The HIF protein 
levels were then measured by analyzing the fluorescent expression of the eYFP 
reporter (Figure 6.6).  HIF protein levels in CHO cells were found to increase with 
decreasing oxygen concentration, reaching a maximum around 0.6% O2.  Further, these 
levels did not strongly change at oxygen concentrations less than 4% O2, suggesting 
that HIF is stabilized over a range of conditions.  Overall, this result demonstrates the 
ability to perform cell studies under controlled oxygen conditions within this microfluidic 
platform. 
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6.4 Conclusions 
This chapter reports the design and characterization of an open-welled 
microfluidic platform that enables cell studies under controlled oxygen conditions.  The 
open-well design of the device enables easy handling and addition of cells and reagents 
by micropipette.  To validate the oxygen concentration within the platform, both 
experimental measurements and computational simulations were performed.  Addition 
of an oxygen impermeable barrier by placing a glass coverslip on top of the device was 
found to decrease oxygen concentration, and the affects of parameters such as 
membrane thickness and media height on oxygen concentration within the device were 
explored.  Further, the microfluidic platform enabled studies of HIF stabilization in CHO 
cells under various oxygen concentrations.  Overall, the discussed microfluidic platform 
provides an opportunity to study the complex relationship between cell behavior and 
hypoxia. 
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6.5 Figures 
 
Figure 6.1.  Schematic of the open-welled microfluidic platform.  [A] Top down view of the microfluidic 
platform’s channels (grey) and cell chamber (blue).  [B] Cross sectional view of the microfluidic platform.  
Cells encapsulated in a 3D gel are introduced into the cell chamber along with media. 
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Figure 6.2.  Computational model developed to simulate the oxygen concentration within the microfluidic 
platform.  The oxygen concentration was simulated at different time points after introducing a gas stream 
with a composition of 0% oxygen into the microfluidic platform. 
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Figure 6.3.  Experimentally measured oxygen concentration in the microfluidic platform.  Gas stream 
composition was varied from 0-5% oxygen.  A membrane thickness of 20 µm and a media height of 1.5 
mm was used during all measurements.  Error bars represent the standard deviation calculated from all 
experiments for each gas composition; experiments were repeated six times. 
 
 
 
Figure 6.4.  Equilibrated oxygen concentration with the top of the microfluidic platform open or coverd.  
The cell chamber was either open to the atmosphere (open top) or covered by a glass coverslip (covered 
top).  A membrane thickness of 20 µm, a media height of 1.5 mm, and a gas stream with 0% oxygen were 
used for all measurements.  Error bars represent the standard deviation calculated from all experiments 
for each gas composition; experiments were repeated six times. 
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Figure 6.5.  Equilibrated oxygen concentration with varying [A] membrane thickness and [B] media 
height.  [A] The membrane thickness was varied from 20-150 µm.  [B] The media height was varied from 
0.5-1.5 mm.  A gas stream with 0% oxygen was introduced into the platform for all measurements.  Error 
bars represent the standard deviation calculated from all experiments for each gas composition; 
experiments were repeated six times. 
 
 
 
Figure 6.6.  Fluorescent expression of HIF-α stabilization in CHO cells at various oxygen concentrations.  
For ease of visualization, a power law was fit to the experimental data.  Error bars represent the standard 
deviation calculated from all experiments; experiments were repeated six times resulting in at least 50 
cells analyzed for each value. 
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CHAPTER 7 
Concluding remarks 
7.1. Conclusions 
The cellular microenvironment can influence cell behavior via interactions with 
other cells [1-4], interactions with the extracellular matrix [5,6], gradients [7,8], and low 
oxygen tensions [9-11].  To more effectively study how cells behave in their native 
microenvironment, advanced tools are required to provide accurate recapitulation of the 
cellular microenvironment [12-14].  Microfluidic platforms enable control over the 
microenvironment due to mixing occurring only by diffusion.  This controlled method of 
mass transport enables knowledge of the spatiotemporal distribution of chemicals within 
the platform.  Further, microfluidic platforms enable real-time imaging of cellular 
behavior due to their compatibility with high resolution microscopy.  These platforms 
also provide a method to systematically explore cell behavior in complex 
microenvironments due to the ability to pattern cells into specific compartments.  As a 
result, microfluidic platforms have been used in a wide range of applications, from 
chemical synthesis to protein crystallization [15-19].  More specifically, microfluidic 
platforms are particularly well suited for studying the individual and coordinated roles of 
cells in complex microenvironments. 
This dissertation reported on the design, fabrication, validation, and application of 
microfluidic platforms for studying neutrophil chemotaxis, intercellular signaling, and cell 
behavior under controlled oxygen concentrations.  Neutrophil chemotaxis was studied 
by employing a microfluidic platform to generate opposing chemoattractant gradients.  
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In the resulting gradients, neutrophils were found to oscillate between the maxima of the 
intermediary chemoattractants LTB4 and IL-8.  By using a platform with barriers 
patterned in the center of the channel, neutrophil migration around a bifurcation was 
studied.  Neutrophils were found to efficiently migrate around small barriers (40 and 100 
µm) while becoming less efficient as the barrier width was increased to 200 µm.  To 
study intercellular signaling, a microfluidic platform was developed and used in 
conjunction with a model cell system.  The complete spatiotemporal distribution of 
signaling molecules was determined throughout the platform by using the model system 
to both experimentally measure and computationally simulate cell-cell communication.  
To study cell behavior under controlled oxygen conditions, an open-welled microfluidic 
platform was developed and characterized.  The open-welled design enables easy 
addition and manipulation of cells.  In addition, by having gas supply channels directly 
underneath the cell chamber, the oxygen concentration within the platform was able to 
be controlled.  Overall, the described platforms represent tools that could potentially 
enable detailed studies of specific cell biology under complex microenvironments. 
7.2. Future directions 
The microfluidic platforms discussed in this dissertation have primarily been used 
for proof-of-principle studies.  These studies have demonstrated the utility of the 
developed microfluidic platforms.  However, for these platforms to reach their potential 
more specific and in depth biological questions need to be addressed.   
Intercellular communication has been demonstrated to affect stem cell 
proliferation and differentiation [20-22], promote tumor growth and metastasis [23-25], 
and to regulate the immune response [26-28].  The microfluidic platform developed in 
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Chapter 4 can be employed to investigate cell-cell signaling in the tumor 
microenvironment.  By utilizing the controlled mass transfer of signaling molecules 
within the microfluidic platform, systematic studies of the affects of stromal cells and 
immune cells on cancer cell growth and proliferation can be performed.  Further, the 
specific interactions between the cell populations can be analyzed and modulated to 
determine the potential for therapeutic targets. 
In solid tumors, regions of low oxygen concentration exist due to poorly formed 
and malfunctioning vasculature [29,30].  These hypoxic regions promote tumor 
progression and metastasis [31-33], increase therapeutic resistance [11,34,35], and 
alter metabolism [36,37].  The microfluidic platform developed in Chapter 6 can be 
utilized to study cancer cell behavior under controlled oxygen concentrations.  More 
specifically, the effect of hypoxia on organellar redox can be studied.  Using genetically 
encoded redox biosensors developed by the Gaskins and Kenis labs, the ratiometric 
response between oxidized and reduced glutathione can be measured under controlled 
oxygen conditions [38,39].  Further, cell metabolism under hypoxia can be investigated 
using these biosensors [40].  Overall, combining the platforms developed in this 
dissertation with sophisticated biological assays will enable detailed study of cell 
behavior in complex microenvironments. 
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